CURRICULUM VITAE · CURRICULUM VITAE ALFREDO CARLO ALTAMURA Posizione accademica Settore...

N. Progr. 8012

Pag. 1 di 27

1.

2.

3.

CURRICULUM VITAE

ALFREDO CARLO ALTAMURA

Posizione accademica

Settore Concorsuale dal 01/10/2011 06/D5 - PSICHIATRIA

Settore Scientifico Disciplinare dal 01/04/2001 MED/25 - PSICHIATRIA

Qualifica Professore Ordinario

Anzianità nel ruolo di professore di I fascia 01/11/1992

Sede universitaria Università degli Studi di MILANO

Dipartimento Dipartimento di SCIENZE NEUROLOGICHE

Posizioni ricoperte precedentemente nel medesimo ateneo o in altri:

dal 01/08/1980 Professore II Fascia Università degli Studi di MILANO

dal 01/11/1992 Professore I Fascia Università degli Studi di CAGLIARI

dal 01/11/1997 Professore I Fascia Università degli Studi di MILANO

Pubblicazioni scientifiche

Pubblicazioni principali

Altre Pubblicazioni

2012 - Articolo in rivistaArosio B, Bulbarelli A, Bastias Candia S, Lonati E, Mastronardi L, Romualdi P, Candeletti S, Gussago C,Galimberti D, Scarpini E, Dell'Osso B, Altamura A.C., MacCarrone M, Bergamaschini L, D'Addario C,Mari D. (2012). Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms inpatients with late-onset Alzheimer's disease.. NEURODEGENERATIVE DISEASES, vol. 10, p. 207-211,ISSN: 1660-28542012 - Articolo in rivistaAltamura A.C., Moliterno D, Paletta S, Buoli M, Dell'osso B, Mauri MC, Bareggi SR. (2012). Effect ofquetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokineticapproach: a prospective observational study.. CLINICAL DRUG INVESTIGATION, vol. 32, p. 213-219,ISSN: 1173-25632012 - Articolo in rivistaD'Addario C, Dell'Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E, Galimberti D, Fenoglio C, Cortini

N. Progr. 8012

Pag. 2 di 27

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

F, Scarpini E, Arosio B, Di Francesco A, Di Benedetto M, Romualdi P, Candeletti S, Mari D,Bergamaschini L, Bresolin N, Maccarrone M, Altamura A.C. (2012). Selective DNA methylation of BDNFpromoter in bipolar disorder: differences among patients with BDI and BDII..NEUROPSYCHOPHARMACOLOGY, vol. 37, p. 1647-1655, ISSN: 0893-133X2012 - Articolo in rivistaGalimberti D, Dell'Osso B, Fenoglio C, Villa C, Cortini F, Serpente M, Kittel-Schneider S, Weigl J,Neuner M, Volkert J, Leonhard C, Olmes DG, Kopf J, Cantoni C, Ridolfi E, Palazzo C, Ghezzi L, BresolinN, Altamura A.C., Scarpini E, Reif A. (2012). Progranulin gene variability and plasma levels in bipolardisorder and schizophrenia.. PLOS ONE, vol. 7, ISSN: 1932-62032012 - Articolo in rivistaD'Addario C, Di Francesco A, Arosio B, Gussago C, Dell'osso B, Bari M, Galimberti D, Scarpini E,Altamura A.C., Mari D, Maccarrone M. (2012). Epigenetic regulation of Fatty Acid amide hydrolase inAlzheimer disease.. PLOS ONE, vol. 7, ISSN: 1932-62032012 - Articolo in rivistaRosa M., Franzini A., Giannicola G., Messina G., Altamura A.C., Priori A. (2012). Hypothalamicoscillations in human pathological aggressiveness.. BIOLOGICAL PSYCHIATRY, ISSN: 0006-32232012 - Articolo in rivistaM. Rosa, A. Franzini, G. Giannicola, G. Messina, A.C. Altamura, A. Priori (2012). Hypothalamicoscillations in human pathological aggressiveness. BIOLOGICAL PSYCHIATRY, ISSN: 0006-3223, doi:10.1016/j.biopsych.2012.06.0072012 - Articolo in rivistaDell'osso B, Glick ID, Baldwin DS, Altamura A.C. (2012). Can Long-Term Outcomes Be Improved byShortening the Duration of Untreated Illness in Psychiatric Disorders A Conceptual Framework. .PSYCHOPATHOLOGY, ISSN: 0254-49622012 - Articolo in rivistaAltamura A.C., Aguglia E, Bassi M, Bogetto F, Cappellari L, De Giorgi S, Fagiolini A, Ferrannini L,Girardi P. (2012). Rethinking the role of long-acting atypical antipsychotics in the community setting. .INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, ISSN: 0268-13152012 - Articolo in rivistaGalimberti D, D'Addario C, Dell'osso B, Fenoglio C, Marcone A, Cerami C, Cappa SF, Palazzo MC,Arosio B, Mari D, Maccarrone M, Bresolin N, Altamura A.C., Scarpini E. (2012). Progranulin gene(GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.. NEUROLOGICAL SCIENCES, ISSN: 1590-34782011 - Articolo in rivistaA. C. Altamura, P. M. Marinaccio, E. P. Nocito, M. Ciabatti, M. Porcellana, L. Magri, C. Bressi (2011).Subjective well-being nel disturbo bipolare : uno studio prospettico preliminare. ITALIAN JOURNAL OFPSYCHOPATHOLOGY, vol. 17, p. 48-53, ISSN: 1592-11072011 - Abstract in rivistaP.M. Marinaccio, E.P. Nocito, M. Ciabatti M, E. Dipasquale, C. Bressi, A.C. Altamura (2011). La duratadi malattia non trattata nel disturbo bipolare è correlata al Subjective Well-being? Uno studioprospettico preliminare. ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 17, p. 161, ISSN: 1592-11072011 - Abstract in rivistaE.P. Nocito, P.M. Marinaccio, M. Ciabatti, R. Fontana, C. Bressi, A.C. Altamura (2011). Insight comeindicatore di esito clinico nel disturbo bipolare: studio longitudinale preliminare. ITALIAN JOURNAL OFPSYCHOPATHOLOGY, vol. 17, p. 162, ISSN: 1592-11072011 - Articolo in rivistaB.M. Dell'osso, M. Palazzo, L. Oldani, A.C. Altamura (2011). The Noradrenergic Action inAntidepressant Treatments : Pharmacological and Clinical Aspects. CNS NEUROSCIENCE &THERAPEUTICS, vol. 17, p. 723-732, ISSN: 1755-5930, doi: 10.1111/j.1755-5949.2010.00217.x2011 - Articolo in rivistaB.M. Dell'osso, N. D'Urso, F. Castellano, M. Ciabatti, A.C. Altamura (2011). Long-Term Efficacy AfterAcute Augmentative Repetitive Transcranial Magnetic Stimulation in Bipolar Depression : A 1-YearFollow-Up Study. THE JOURNAL OF ECT, vol. 27, p. 141-144, ISSN: 1095-0680, doi:10.1097/YCT.0b013e3181f666012011 - Articolo in rivistaB.M. Dell'osso, M. Buoli, S. Bortolussi, G. Camuri, V. Vecchi, A.C. Altamura (2011). Patterns of Axis Icomorbidity in relation to age in patients with Bipolar Disorder : A cross-sectional analysis. JOURNAL

N. Progr. 8012

Pag. 3 di 27

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

OF AFFECTIVE DISORDERS, vol. 130, p. 318-322, ISSN: 0165-0327, doi: 10.1016/j.jad.2010.10.0082011 - Articolo in rivistaA. C. Altamura, M. Porcellana, P. M. Marinaccio, M. Ciabatti, E. P. Nocito, L. Magri, C. Bressi (2011). Isit possible to assess subjective well-being among bipolar inpatients? An 18-week follow-up study.GENERAL HOSPITAL PSYCHIATRY, vol. 33, p. 185-190, ISSN: 0163-8343, doi:10.1016/j.genhosppsych.2011.01.0032011 - Articolo in rivistaC. Bressi, M. Porcellana, P.M. Marinaccio, E.P. Nocito, M. Ciabatti, L. Magri, A.C. Altamura (2011). Theassociation between insight and symptoms in bipolar inpatients : an italian prospective study.EUROPEAN PSYCHIATRY, ISSN: 0924-9338, doi: 10.1016/j.eurpsy.2011.09.0022011 - Articolo in rivistaB. Dell'Osso, S. Zanoni, R. Ferrucci, M. Vergari, F. Castellano, N. D'Urso, C. Dobrea, B. Benatti, C.Arici, A. Priori, A.C. Altamura (2011). Transcranial Direct Current Stimulation For The OutpatientTreatment Of Drug-Resistant Depressed Patients. EUROPEAN PSYCHIATRY, ISSN: 0924-9338, doi:10.1016/j.eurpsy.2011.02.0082011 - Articolo in rivistaB. Dell'Osso, A. Priori, A.C. Altamura (2011). Efficacy and safety of transcranial direct currentstimulation in major depression. BIOLOGICAL PSYCHIATRY, ISSN: 0006-3223, doi:10.1016/j.biopsych.2010.12.0312011 - Articolo in rivistaA.C. Altamura, M. Buoli, M.C. Mauri (2011). Haloperidol versus second-generation antipsychotics inthe long-term treatment of schizophrenia : a 4-year follow-up naturalistic study. JOURNAL OFCLINICAL PSYCHOPHARMACOLOGY, vol. 31, p. 661-663, ISSN: 0271-0749, doi:10.1097/JCP.0b013e31822c989a2011 - Articolo in rivistaA.C. Altamura, M. Buoli, B.M. Dell'Osso, A. Albano, M. Serati, F. Colombo, S.M. Pozzoli, J. Angst(2011). The impact of brief depressive episodes on the outcome of bipolar disorder and majordepressive disorder : a 1-year prospective study. JOURNAL OF AFFECTIVE DISORDERS, vol. 134, p.133-137, ISSN: 0165-0327, doi: 10.1016/j.jad.2011.06.0182011 - Articolo in rivistaM.C. Mauri, C. Rovera, S. Paletta, I.F. De Gaspari, M. Maffini, A.C. Altamura (2011). Aggression andpsychopharmacological treatments in major psychosis and personality disorders during hospitalisation.PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 35, p. 1631-1635,ISSN: 0278-5846, doi: 10.1016/j.pnpbp.2011.05.0082011 - Articolo in rivistaM. Maes, B. Leonard, A. Fernandez, M. Kubera, G. Nowak, R. Veerhuis, A. Gardner, P. Ruckoanich, M.Geffard, A.C. Altamura, P. Galecki, M. Berk (2011). (Neuro)inflammation and neuroprogression asnew pathways and drug targets in depression : From antioxidants to kinase inhibitors. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 35, p. 659-663, ISSN: 0278-5846,doi: 10.1016/j.pnpbp.2011.02.0192011 - Articolo in rivistaA.C. Altamura, M. Serati, A. Albano, R.A. Paoli, I.D. Glick, B.M. Dell'Osso (2011). An epidemiologicand clinical overview of medical and psychopathological comorbidities in major psychoses. EUROPEANARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, vol. 261, p. 489-508, ISSN: 0940-1334,doi: 10.1007/s00406-011-0196-42011 - Articolo in rivistaI.D. Glick, C.U. Correll, A.C. Altamura, S.R. Marder, J.G. Csernansky, P.J. Weiden, S. Leucht, J.M.Davis (2011). Mid-term and long-term efficacy and effectiveness of antipsychotic medications forschizophrenia : a data-driven, personalized clinical approach. JOURNAL OF CLINICAL PSYCHIATRY,vol. 72, p. 1616-1627, ISSN: 0160-6689, doi: 10.4088/JCP.11r069272011 - Articolo in rivistaA.C. Altamura, L. Lietti, C.R.M. Dobrea, B. Benatti, C. Arici, B.M. Dell'Osso (2011). Mood stabilizers forpatients with bipolar disorder : the state of the art. EXPERT REVIEW OF NEUROTHERAPEUTICS, vol.11, p. 85-99, ISSN: 1473-7175, doi: 10.1586/ERN.10.1812011 - Articolo in rivistaB.M. Dell'Osso, G.L.c. Camuri, F. Castellano, V. Vecchi, M. Benedetti, S. Bortolussi, A.C. Altamura(2011). Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS)

N. Progr. 8012

Pag. 4 di 27

28.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

39.

40.

for the Treatment of Major Depression. CLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH,vol. 7, p. 167-177, ISSN: 1745-01792011 - Articolo in rivistaG.M. Goodwin, M. Abbar, T.E. Schlaepfer, H. Grunze, R.W. Licht, F. Bellivier, K.N. Fountoulakis, A.C.Altamura, W. Pitchot, H. Ågren, E. Holsboer-Trachsler, E. Vieta (2011). Aripiprazole in patients withbipolar mania and beyond : an update of practical guidance. CURRENT MEDICAL RESEARCH ANDOPINION, vol. 27, p. 2285-2299, ISSN: 0300-7995, doi: 10.1185/03007995.2011.6283802011 - Articolo in rivistaA.C. Altamura, M. Serati, M. Buoli, B.M. Dell'Osso (2011). Augmentative quetiapine inpartial/nonresponders with generalized anxiety disorder : a randomized, placebo-controlled study.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol. 26, p. 201-205, ISSN: 0268-1315, doi:10.1097/YIC.0b013e3283457d732011 - Articolo in rivistaA.C. Altamura, O.A. Andreassen, D. Aarsland, T.C. Baghai, D.S. Baldwin, D. Baron, M. Bauer, R.H.Belmaker, P. Blier, P. Boyer, W.E. Bunney, G. Burrows, W. Fleischhacker, D. Flores, K.N. Fountoulakis,W.F. Gattaz, G. Goodwin, G. Heinze, I. Hindmarch, C. Hoschl, S. Kasper, P.K. Sorensen, S.Z. Langer,B. Leonard, J.J. Lopez-Ibor, U. Malt, B. Millet, H.J. Möller, J. Monti, B. Müller-Oerlinghausen, A.Okasha, J.P. Olie, E.S. Paykel, G. Racagni, P. Renshaw, R. Rosenberg, W. Rutz, B. Saletu, G. Sedvall,B. Singh, D.J. Stein, R. Tandon, M. Versiani, E. Vieta, G. Wegener, J. Zohar (2011). General andcomparative efficacy and effectiveness of antidepressants in the acute treatment of depressivedisorders : a report by the WPA section of pharmacopsychiatry. EUROPEAN ARCHIVES OFPSYCHIATRY AND CLINICAL NEUROSCIENCE, vol. 261, p. 207-245, ISSN: 0940-1334, doi:10.1007/s00406-011-0259-62011 - Articolo in rivistaA. Fiorentini, L.S. Volonteri, F. Dragogna, C. Rovera, M. Maffini, M.C. Mauri, A.C. Altamura (2011).Substance-induced psychoses : a critical review of the literature. CURRENT DRUG ABUSE REVIEWS,vol. 4, p. 228-240, ISSN: 1874-47372011 - Monografia o trattato scientificoALTAMURA A.C., BOGETTO F., CASACCHIA M., MUSCETTOLA G., MAJ M. (2011). MANUALE DITERAPIA PSICHIATRICA INTEGRATA - TERAPIE SOMATICHE E PSICOTERAPIA. . vol. 1, Roma:IlPensiero Scientifico Editore2011 - Articolo in rivistaALTAMURA A.C., BUOLI M., SERATI M. (2011). DURATION OF ILLNESS AND DURATION OFUNTREATED ILLNESS IN RELATION TO DRUG RESPONSE IN PSYCHIATRIC DISORDERS..NEUROPSYCHIATRY, vol. 1, p. 81-90, ISSN: 1758-20082011 - Articolo in rivistaBaghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, MaltUF, Stein D, Versiani M, Möller HJ, Altamura A.C. (2011). General and comparative efficacy andeffectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPAsection of pharmacopsychiatry.. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICALNEUROSCIENCE, vol. 261, p. 207-245, ISSN: 0940-13342010 - Articolo in rivistaB. Dell’Osso, A.C. Altamura (2010). Duration of Untreated Psychosis and Duration of Untreated Illness: New Vistas. CNS SPECTRUMS, vol. 15, p. 238-246, ISSN: 1092-85292010 - Articolo in rivistaDELL'OSSO B, ALTAMURA A.C. (2010). Duration of untreated psychosis and duration of untreatedillness: new vistas. CNS SPECTRUMS, vol. 15(4), p. 238-246, ISSN: 1092-85292010 - Abstract in rivistaL. Lietti, L. Oldani, G. Camuri, B. Benatti, E. Catenacci, V. Vecchi, B. Dell'Osso, C. Bressi, A. C.Altamura (2010). Effetti dei sintomi sottosoglia nel disturbo di panico e nel disturbo d’ansiageneralizzato : un’analisi trasversale. ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 16, p. 219,ISSN: 1592-11072010 - Articolo in rivistaM. Buoli, B.M. Dell'osso, M.F. Bosi, A.C. Altamura (2010). Slow vs standard up-titration of paroxetinein the treatment of panic disorder : A prospective randomized trial. PSYCHIATRY AND CLINICALNEUROSCIENCES, vol. 64, p. 612-619, ISSN: 1323-1316, doi: 10.1111/j.1440-1819.2010.02136.x2010 - Articolo in rivista

N. Progr. 8012

Pag. 5 di 27

40.

41.

42.

43.

44.

45.

46.

47.

48.

49.

50.

51.

52.

53.

A.C. Altamura, G. Camuri, B.M. Dell'Osso (2010). Una revisione critica sul ruolo della durata dimalattia non trattata nei disturbi psichiatrici. RIVISTA DI PSICHIATRIA, vol. 45, p. 197-208, ISSN:0035-64842010 - Abstract in rivistaM. Serati, M. Buoli, M. Bulgheroni, L. Airaghi, P. Bonara, S. R. Fargion, A. C. Altamura (2010). Feverassociated with psychomotor retardation in a middle-age man. INTERNAL AND EMERGENCYMEDICINE, vol. 5, p. S246, ISSN: 1828-0447, doi: 10.1007/s11739-010-0506-22010 - Articolo in rivistaB. Dell'Osso, M. Buoli, E. Hollander, A.C. Altamura (2010). Duration of untreated illness as a predictorof treatment response and remission in obsessive-compulsive disorder. THE WORLD JOURNAL OFBIOLOGICAL PSYCHIATRY, vol. 11, p. 59-65, ISSN: 1562-29752010 - Articolo in rivistaA.C. Altamura, G.M. Goodwin (2010). How Law 180 in Italy has reshaped psychiatry after 30 years :past attitudes, current trends and unmet needs. BRITISH JOURNAL OF PSYCHIATRY, vol. 197, p.261-262, ISSN: 0007-12502010 - Articolo in rivistaA.C. Altamura, B. Dell'osso, H.A. Berlin, M. Buoli, R. Bassetti, E. Mundo (2010). Duration of untreatedillness and suicide in bipolar disorder : a naturalistic study. EUROPEAN ARCHIVES OF PSYCHIATRYAND CLINICAL NEUROSCIENCE, vol. 260, p. 385-391, ISSN: 0940-13342010 - Articolo in rivistaD.S. Baldwin, C. Allgulander, A.C. Altamura, J. Angst, B. Bandelow, J. den Boer, P. Boyer, S. Davies,B. Dell'osso, E. Eriksson, N. Fineberg, M. Fredrikson, A. Herran, E. Maron, A. Metspalu, D. Nutt, N. vander Wee, J.L. Vázquez-Barquero, J. Zohar (2010). Manifesto for a European Anxiety DisordersResearch Network. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 20, p. 426-432, ISSN:0924-977X2010 - Articolo in rivistaB. Dell'Osso, M. Buoli, D.S. Baldwin, A.C. Altamura (2010). Serotonin norepinephrine reuptakeinhibitors (SNRIs) in anxiety disorders : a comprehensive review of their clinical efficacy. HUMANPSYCHOPHARMACOLOGY, vol. 25, p. 17-29, ISSN: 0885-6222, doi: 10.1002/hup.10742010 - Articolo in rivistaA.C. Altamura, I.D. Glick (2010). Designing outcome studies to determine efficacy and safety ofantipsychotics for 'real world' treatment of schizophrenia. INTERNATIONAL JOURNAL OFNEUROPSYCHOPHARMACOLOGY, vol. 13, p. 971-973, ISSN: 1461-1457, doi:10.1017/S14611457099912712010 - Articolo in rivistaA.C. Altamura, M. Buoli, A. Albano, B. Dell'Osso (2010). Age at onset and latency to treatment(duration of untreated illness) in patients with mood and anxiety disorders : a naturalistic study.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol. 25, p. 172-179, ISSN: 0268-13152010 - Articolo in rivistaA.C. Altamura, E.M. Mundo, E. Cattaneo, S. Pozzoli, B.M. Dell'Osso, M. Gennarelli, C. Vergani, D.L.Trabattoni, B. Arosio, M.S. Clerici (2010). The MCP-1 gene (SCYA2) and mood disorders : preliminaryresults of a case-control association study. NEUROIMMUNOMODULATION, vol. 17, p. 126-131, ISSN:1021-7401, doi: 10.1159/0002586962010 - Articolo in rivistaB. Dell’Osso, H.A. Berlin, M. Serati, A.C. Altamura (2010). Neuropsychobiological aspects, comorbiditypatterns and dimensional models in borderline personality disorder. NEUROPSYCHOBIOLOGY, vol. 61,p. 169-179, ISSN: 0302-282X, doi: 10.1159/0002977342010 - Articolo in rivistaALTAMURA A.C. (2010). DAL CONCETTO DI ANTIPSICOTICO A QUELLO DI "NORMOSTABILIZZATOREMULTIDIMENSIONALE": IL PERCORSO CLINICO-TERAPEUTICO DELLA SCHIZOFRENIA. ITALIANJOURNAL OF PSYCHOPATHOLOGY, vol. 16, p. 87-103, ISSN: 1592-11072010 - Articolo in rivistaDELL'OSSO B, BAREGGI SR, PALAZZO MC, CAMURI G, BORTOLUSSI S, ALTAMURA A.C. (2010). DAICOMPOSTI AD AZIONE DUALE A QUELLI A TRIPLICE AZIONE: CONSIDERAZIONI SULLO SVILUPPO DIUNA CLASSE DI ANTIDEPRESSIVI.. ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 16, p. 114-125,ISSN: 1592-11072010 - Articolo in rivista

N. Progr. 8012

Pag. 6 di 27

53.

54.

55.

56.

57.

58.

59.

60.

61.

62.

63.

64.

65.

66.

COLASANTI A, PALETTA S, MOLITERNO D, MAZZOCCHI A, MAURI MC, ALTAMURA A.C. (2010).SYMPTOM DIMENSIONS AS PREDICTORS OF CLINICAL OUTCOME, DURATION OF HOSPITALIZATIONAND AGGRESSIVE BEHAVIOURS IN ACUTELY HOSPITALIZED PATIENTS WITH PSYCHOTICEXACERBATION.. CLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH, vol. 6, p. 72-78,ISSN: 1745-01792010 - Abstract in rivistaB. Dell'Osso, S. Zanoni, F. Castellano, C. Dobrea, B. Benatti, C. Arici, R. Ferrucci, M. Vergari, A. Priori,A. Altamura (2010). Transcranial direct current stimulation in patients with treatment-resistant majordepressive episode. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 20, p. S341-S342, ISSN:0924-977X2010 - Articolo in rivistaA. Priori, R. Ferrucci, L. Tadini, M. Vergari, S. Zanoni, C. Dobrea, B. Benatti, C. Arici, M. Bortolomasi,M. Giacopuzzi, B. Dell'Osso, A.C. Altamura (2010). Tanscranial direct current stimulation indepression: a comparison between therapeutic effects obtained in hospitalized vs non-hospitalizedpatients. EUROPEAN PSYCHIATRY, vol. 25, p. 176, ISSN: 0924-9338, doi:10.1016/S0924-9338(10)70176-0,2009 - Articolo in rivistaC. Bressi, M. Porcellana, O. Gambini, L. Madia, R. Muffatti, A. Peirone, S. Zanini, A. Erlicher, S.Scarone, A.C. Altamura (2009). Burnout among psychiatrists in Milan : a multicenter survey.PSYCHIATRIC SERVICES, vol. 60, p. 985-988, ISSN: 1075-27302009 - Articolo in rivistaM. Clerici, B. Arosio, E. Mundo, E. Cattaneo, S. Pozzoli, B. Dell'osso, C. Vergani, D. Trabattoni, A.C.Altamura (2009). Cytokine polymorphisms in the pathophysiology of mood disorders. CNSSPECTRUMS, vol. 14, p. 419-425, ISSN: 1092-85292009 - Articolo in rivistaB. Dell'Osso, A. Dario, M. Ciabatti, G. Camuri, L. Oldani, I. Balossi, A.C. Altamura (2009). Vagus nervestimulation in treatment-resistant bipolar depression. CLINICAL NEUROPSYCHIATRY, vol. 6, p.252-258, ISSN: 1724-49352009 - Abstract in rivistaB. Dell’Osso, A. Dario, M. Ciabatti, G. Camuri, L. Oldani, AC. Altamura (2009). Vagus nervestimulation in treatment resistant depression: an Italian case-series. THE WORLD JOURNAL OFBIOLOGICAL PSYCHIATRY, ISSN: 1562-29752009 - Articolo in rivistaB.M. Dell'Osso, A.C. Altamura (2009). Augmentative transcranial magnetic stimulation (TMS)combined with brain navigation in drug-resistant rapid cycling bipolar depression : a case report ofacute and maintenance efficacy. THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, vol. 10, p.673-676, ISSN: 1562-29752009 - Abstract in rivistaAC. Altamura (2009). Duration of untreated psychosis: is it a criterion for outcome prediction?. THEWORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, ISSN: 1562-29752009 - Articolo in rivistaB. Dell'Osso, G. Camuri, H. Berlin, M. Serati, A.C. Altamura (2009). Un approccio dimensionale aldisturbo di personalità borderline. ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 15, p. 48-63, ISSN:1592-11072009 - Abstract in rivistaC. Bressi, M. Porcellana, C. Manoussakis, P. Marinaccio, V. Vitali, A.C. Altamura (2009). Pazienti acuticon diagnosi di disturbo bipolare : studio preliminare sulle modificazioni dell’Insight durante ilricovero. ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 15, p. 185, ISSN: 1592-11072009 - Articolo in rivistaALTAMURA A.C., P. MARINACCIO, M. PORCELLANA, M. CIABATTI, E. LAPERTOSA, BRESSI C (2009).Subjective Well-being in pazienti bipolari : modificazioni durante il ricovero. ITALIAN JOURNAL OFPSYCHOPATHOLOGY, vol. 15, p. 181, ISSN: 1592-11072009 - Articolo in rivistaC. Bressi, A.C. Altamura (2009). Subjective well-being e insight nei pazienti con disturbi bipolari :modificazioni durante il ricovero e correlazioni con le variabili cliniche e soggettive al follow-up.ITALIAN JOURNAL OF PSYCHOPATHOLOGY, vol. 15, p. 151, ISSN: 1592-11072009 - Abstract in rivista

N. Progr. 8012

Pag. 7 di 27

66.

67.

68.

69.

70.

71.

72.

73.

74.

75.

76.

77.

78.

79.

80.

A.C. Altamura, P. Marinaccio, M. Porcellana, M. Ciabatti, E. Lapertosa, C. Bressi (2009). SubjectiveWell-being in pazienti bipolari : modificazioni durante il ricovero. ITALIAN JOURNAL OFPSYCHOPATHOLOGY, vol. 15, p. 181, ISSN: 1592-11072009 - Articolo in rivistaA.C. Altamura (2009). A proposito della Legge 180 trent’anni dopo : riflessioni su una Psichiatria checambia (e sul ruolo dello psichiatra). RIVISTA DI PSICHIATRIA, vol. 44, p. 145-148, ISSN: 0035-64842009 - Abstract in rivistaS. Pozzoli, MC. Palazzo, F. Colombo, A. Albano, E. Cattaneo, G. Colombini, B. Dell’Osso, AC. Altamura(2009). Brief Depressive Episodes and Outcome in Mood Disorders: a naturalistic study. WORLDPSYCHIATRY, vol. 8, p. 176-177, ISSN: 1723-86172009 - Articolo in rivistaG. Racagni, AC. Altamura (2009). What therapeutic innovations for patients with major depression?.WORLD PSYCHIATRY, vol. 8, p. 311, ISSN: 1723-86172009 - Abstract in rivistaM. Buoli, G. Colombini, L. Lietti, M. Serati, G. Camuri, V. Vecchi, B. Dell’Osso, AC. Altamura (2009).Psychiatric and medical comorbidity in different classes of age: a retrospective study in bipolarpatients. WORLD PSYCHIATRY, vol. 8, p. 180, ISSN: 1723-86172009 - Abstract in rivistaAC. Altamura, G. Colombini, B. Dell’Osso (2009). Relevance and treatment of negative symptoms inschizophrenia. WORLD PSYCHIATRY, vol. 8, p. 22, ISSN: 1723-86172009 - Articolo in rivistaA.C. Altamura (2009). Law 180 after 30 years - reflections on unmet needs and risks of loss ofidentity for Italian psychiatrists. ACTA PSYCHIATRICA SCANDINAVICA, vol. 120, p. 501-502, ISSN:0001-690X2009 - Abstract in rivistaM. Buoli, B. Dell’Osso, FL. Lopes, S. Bortolussi, B. Benatti, AC. Altamura (2009). Paroxetine in thetreatment of panic disorder: a comparison between slow and standard up-titrations. EUROPEANNEUROPSYCHOPHARMACOLOGY, vol. 19, p. 606, ISSN: 0924-977X, doi:10.1016/S0924-977X(09)70972-12009 - Abstract in rivistaB. Dell’Osso, M. Buoli, G. Colombini, S. Bortolussi, B. Benatti, MC. Palazzo, AC. Altamura (2009).Outcome predictors in patients with obsessive compulsive disorder: a prospective naturalistic study.EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 19, p. 588, ISSN: 0924-977X, doi:10.1016/S0924-977X(09)70941-12009 - Abstract in rivistaB. Dell’Osso, M. Buoli, A. Albano, S. Bortolussi, B. Benatti, I. Balossi, L. Oldani, AC. Altamura (2009).Duloxetine versus iv Citalopram in partial/non responder depressed patients: a randomizedplacebo-controlled study. EUROPEAN NEUROPSYCHOPHARMACOLOGY, ISSN: 0924-977X, doi:10.1016/S0924-977X(09)70631-52009 - Abstract in rivistaM. Buoli, L. Oldani, M. Serati, A. Albano, M. Ciabatti, B. Dell’Osso, AC. Altamura (2009). Vagus NerveStimulation in treatment-resistant depression: an Italian case-series. INTERNATIONAL JOURNAL OFPSYCHIATRY IN CLINICAL PRACTICE, vol. 13, p. 24-25, ISSN: 1365-15012009 - Abstract in rivistaM. Buoli, S. Bortolussi, L. Oldani, MC. Palazzo, G. Camuri, B. Benatti, B. Dell’Osso, AC. Altamura(2009). Psychiatric comorbidity in bipolar disorder: which association prevail in different age groups.INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol. 13, p. 25, ISSN: 1365-15012009 - Articolo in rivistaAC. Altamura (2009). Early intervention and continuity as pillars of modern psychopharmacotherapy.INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol. 13, p. 8, ISSN: 1365-15012009 - Articolo in rivistaB. Dell'Osso, M. Buoli, R. Riundi, N. D'Urso, S. Pozzoli, R. Bassetti, E. Mundo, A.C. Altamura (2009).Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorderand different age at onset. NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 5, p. 399-404, ISSN:1176-63282009 - Contributo in volume (Capitolo o Saggio)B. M. Dell'Osso, H. Berlin, M. Serati, A. C. Altamura. (2009). Neurophysiology, comorbidity and

N. Progr. 8012

Pag. 8 di 27

80.

81.

82.

83.

84.

85.

86.

87.

88.

89.

90.

91.

92.

93.

dimensional models in borderline personality disorder : critical issues for treatment. In: Borderlinepersonality disorder : new research. p. 59-80, Nova Science Publishers Inc., ISBN:978-1-60692-460-02009 - Articolo in rivistaB. Dell’Osso, E. Mundo, N. D’Urso, S. Pozzoli, M. Buoli, M.T. Ciabatti, V. Bellina, M. Massimini, M.Rosanova, M. Mariotti, A.C. Altamura (2009). Augmentative repetitive navigated transcranial magneticstimulation (rTMS) in drug-resistant bipolar depression. BIPOLAR DISORDERS, vol. 11, p. 76-81,ISSN: 1398-5647, doi: 10.1111/j.1399-5618.2008.00651.x2009 - Abstract in rivistaN. D’Urso, F. Castellano, I. Balossi, B. Dell’Osso, AC. Altamura (2009). Demographic and clinicalfeatures of patients with bipolar disorder and substance abuse/dependence. WORLD PSYCHIATRY, vol.8, p. 240, ISSN: 1723-86172009 - Abstract in rivistaS. Zanoni, F. Castellano, N. D’Urso, C. Dobrea, B. Benatti, C. Arici, R. Ferrucci, M. Vergari, B.Dell’Osso, A. Priori, AC. Altamura (2009). Transcranial Direct Current Stimulation (tDCS) in patientswith Major Depressive Episode. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE,vol. 13, p. 47, ISSN: 1365-15012009 - Abstract in Atti di convegnoB.M. Dell’Osso, M. Rumi, G.M. Prati, A.M. Aghemo, R. D’Ambrosio, I. Balossi, N. D’Urso, F. Castellano,M. Palazzo, M. Colombo, A.C. Altamura (2009). Prevalence of psychiatric disorders during PEG –Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated. In: Abstracts of the9th World Congress of Biological Psychiatry. Paris, 2009, p. 415-416, World Federation of Societies ofBiological Psychiatry, doi: 10.3284/wfsbp.2009.12009 - Abstract in rivistaM.C. Mauri, A.C. Altamura, G. Giobbio, M. Buoli, F. Dragogna, D. Moliterno, M. Maffini, M. Serati(2009). Haloperidol and atipical antypsychotics in the long-term treatment of psychotic disorders :preliminary data from a naturalistic study. THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, ISSN:1562-29752009 - Articolo in rivistaDell'Osso B., Altamura A.C. (2009). Augmentative transcranial magnetic stimulation (TMS) combinedwith brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute andmaintenace efficacy.. THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, vol. 10, p. 673-676, ISSN:1562-29752009 - Contributo in volume (Capitolo o Saggio)ALTAMURA A.C., DELL'OSSO B., CAMURI G., OLDANI L. (2009). Current and future perspectives onVagus Nerve Stimulation in treatment resistant depression.. In: Deep Brain Stimulation: Applications,Complications and side effects.. p. 177-1882009 - Contributo in volume (Capitolo o Saggio)ALTAMURA A.C., DRAGOGNA F., POZZOLI S., MAURI MC (2009). Schizophrenia: differential diagnosisand comorbidity. In: Schizophrenia. p. 52-69, INFORMA HEALTH CARE2009 - Monografia o trattato scientificoAltamura A.C. (2009). Fondamenti di Psichiatria e Psicofarmacologia. ROMA:Il Pensiero ScientificoEditore- Roma2008 - Articolo in rivistaM. Pugliatti, P. Sobocki, E. Beghi, S. Pini, G.B. Cassano, A.C. Altamura, S. Pozzoli, G. Rosati (2008).Cost of disorders of the brain in Italy. NEUROLOGICAL SCIENCES, vol. 29, p. 99-107, ISSN:1590-18742008 - Articolo in rivistaB. Dell'Osso, E. Mundo, D. Marazziti, A.C. Altamura (2008). Switching from serotonin reuptakeinhibitors to duloxetine in patients with resistant obsessive compulsive disorder : a case series.JOURNAL OF PSYCHOPHARMACOLOGY, vol. 22, p. 210-213, ISSN: 0269-8811, doi:10.1177/02698811070798652008 - Articolo in rivistaG. Messina, E. Colombo, E. Cassinerio, F. Ferri, R. Curti, C. Altamura, M.D. Cappellini (2008).Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. INTERNAL ANDEMERGENCY MEDICINE, vol. 3, p. 339-343, ISSN: 1828-04472008 - Articolo in rivista

N. Progr. 8012

Pag. 9 di 27

93.

94.

95.

96.

97.

98.

99.

100.

101.

102.

103.

104.

105.

106.

A.C. Altamura, B. Dell'Osso, N. D'Urso, M. Russo, S. Fumagalli, E. Mundo (2008). Duration ofuntreated illness as a predictor of treatment response and clinical course in generalized anxietydisorder. CNS SPECTRUMS, vol. 13, p. 415-422, ISSN: 1092-85292008 - Articolo in rivistaB. Dell'Osso, A. Allen, A.C. Altamura, M. Buoli, E. Hollander (2008). Impulsive-compulsive buyingdisorder : clinical overview. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, vol. 42, p.259-266, ISSN: 0004-86742008 - Articolo in rivistaA.C. Altamura, D. Armadoros, M. Jaeger, R. Kernish, J. Locklear, H.P. Volz (2008). Importance of openaccess to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder : a Europeanperspective. CURRENT MEDICAL RESEARCH AND OPINION, vol. 24, p. 2271-2282, ISSN: 0300-79952008 - Articolo in rivistaA.C. Altamura, B. Dell'Osso, S. Vismara, E. Mundo (2008). May duration of untreated illness influencethe long-term course of major depressive disorder?. EUROPEAN PSYCHIATRY, vol. 23, p. 92-96, ISSN:0924-9338, doi: 10.1016/j.eurpsy.2007.11.0042008 - Articolo in rivistaA.C. Altamura, B. Dell'Osso, M. Buoli, M. Bosi, E. Mundo (2008). Short-term intravenous citalopramaugmentation in partial/nonresponders with major depression : a randomized placebo-controlledstudy. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol. 23, p. 198-202, ISSN: 0268-1315,doi: 10.1097/YIC.0b013e3282fe9d542008 - Articolo in rivistaA.C. Altamura, E. Mundo, B. Dell'Osso, G. Tacchini, M. Buoli, J.R. Calabrese (2008). Quetiapine andclassical mood stabilizers in the long-term treatment of Bipolar Disorder : a 4-year follow-upnaturalistic study. JOURNAL OF AFFECTIVE DISORDERS, vol. 110, p. 135-141, ISSN: 0165-0327, doi:10.1016/j.jad.2008.01.0172008 - Articolo in rivistaA.C. Altamura, B. Dell'Osso, M. Buoli, S. Zanoni, E. Mundo (2008). Intravenous augmentativecitalopram versus clomipramine in partial/nonresponder depressed patients : a short-term, low dose,randomized, placebo-controlled study. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, vol. 28, p.406-410, ISSN: 0271-0749, doi: 10.1097/JCP.0b013e31817d59312008 - Articolo in rivistaA.C. Altamura, J.M. Goikolea (2008). Differential diagnoses and management strategies in patientswith schizophrenia and bipolar disorder. NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 4, p.311-317, ISSN: 1176-63282008 - Articolo in rivistaL. Dell'Osso, M.K. Shear, C. Carmassi, P. Rucci, J.D. Maser, E. Frank, J. Endicott, L. Lorettu, A.C.Altamura, B. Carpiniello, F. Perris, C. Conversano, A. Ciapparelli, M. Carlini, N. Sarno, G.B. Cassano(2008). Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum(SCI-TALS). CLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH, vol. 4, p. 1-8, ISSN:1745-01792008 - Articolo in rivistaTandon R., Belmaker R.H., Gattaz WF, Lopez-Ibor JJ Jr, Okasha A., Singh B., Stein DJ, Olie J.P.,Fleischacker WW, Moeller HJ, Altamura A.C. (2008). World Psychiatric association pharmcopsychiatrysection statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.SCHIZOPHRENIA RESEARCH, vol. 100, p. 20-38, ISSN: 0920-99642008 - Articolo in rivistaAltamura A.C., Dell'Osso B., Serati M., Ciabatti M., Buoli M. (2008). Recent assessment on theneurobiology of major depression, a critical review.. RIVISTA DI PSICHIATRIA, vol. 43, p. 185-207,ISSN: 2038-25022008 - Articolo in rivistaMOLLER HJ, BALDWIN DS, GOODWIN J, KASPER S, OKASHA A, STEIN DJ, TANDON R, VERSIANI M,MALT U, SALETU B, ALTAMURA A.C. (2008). Do SSRIs or antidepressants in general increasesuicidality? WPA Section on Pharmacopsychiatry: consensus statement.. EUROPEAN ARCHIVES OFPSYCHIATRY AND CLINICAL NEUROSCIENCE, vol. 258 S, p. 3-23, ISSN: 0940-13342008 - Articolo in rivistaALTAMURA A.C. (2008). New acquisitions on pharmacological treatment.. QUADERNI ITALIANI DIPSICHIATRIA, vol. 27, p. 43-44, ISSN: 0393-0645

N. Progr. 8012

Pag. 10 di 27

106.

107.

108.

109.

110.

111.

112.

113.

114.

115.

116.

117.

118.

119.

120.

2007 - Articolo in rivistaALTAMURA A.C. (2007). Bipolar spectrum and drug addiction. JOURNAL OF AFFECTIVE DISORDERS,ISSN: 0165-03272007 - Articolo in rivistaANGST J, GAMMA A, PEZAWAS L, AJDACIC-GROSS V, EICH D, RÖSSLER W, ALTAMURA A.C. (2007).Parsing the clinical phenotype of depression: the need to integrate brief depressive episodes. ACTAPSYCHIATRICA SCANDINAVICA, vol. 115(3), p. 221-228, ISSN: 0001-690X2007 - Articolo in rivistaROBERT PH, MICHEL E, VAN OS J, ALTAMURA A.C., BOBES J, GERLACH J, HELLEWELL JS, KASPER S,NABEL D (2007). 2-COM: presentation of an instrument facilitating communication between physiciansand carers in daily practice. L'ENCÉPHALE, vol. 33(1), p. 60-64, ISSN: 0013-70062007 - Articolo in rivistaALTAMURA A.C., BOBO W.V, MELTZER H.Y (2007). Factors affecting outcome in schizophrenia andtheir relevance for psychopharmacological treatment. INTERNATIONAL CLINICALPSYCHOPHARMACOLOGY, ISSN: 0268-13152007 - Articolo in rivistaALTAMURA A.C., DELL'OSSO B, MUNDO E, DELL'OSSO L (2007). Duration of untreated illness in majordepressive disorder: a naturalistic study. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, ISSN:1368-50312007 - Articolo in rivistaDELL'OSSO B, ALTAMURA A.C., MUNDO E, MARAZZITI D, HOLLANDER E (2007). Diagnosis andtreatment of obsessive-compulsive disorder and related disorders. INTERNATIONAL JOURNAL OFCLINICAL PRACTICE, ISSN: 1368-50312007 - Articolo in rivistaBAREGGI SR, MUNDO E, DELL'OSSO B, ALTAMURA A.C. (2007). The use of escitalopram beyondmajor depression: pharmacological aspects, efficacy and tolerability in anxiety disorders. EXPERTOPINION ON DRUG METABOLISM & TOXICOLOGY, vol. 3(5), p. 741-753, ISSN: 1742-52552007 - Articolo in rivistaA.C. Altamura, E. Mundo, R. Bassetti, A. Green, J.P. Lindenmayer, L. Alphs, H.Y. Meltzer (2007).Transcultural differences in suicide attempters : analysis on a high-risk population of patients withschizophrenia or schizoaffective disorder. SCHIZOPHRENIA RESEARCH, vol. 89, p. 140-146, ISSN:0920-9964, doi: 10.1016/j.schres.2006.08.0232007 - Articolo in rivistaDell'Osso B, Hollander E, Marazziti, Mundo E, Altamura A.C. (2007). Diagnosis and treatment ofobsessive-compulsive disorder and related disorders.. INTERNATIONAL JOURNAL OF CLINICALPRACTICE, vol. 61, p. 98-104, ISSN: 1742-12412007 - Articolo in rivistaDell'Osso B., Marazziti D., Hollander E., Altamura A.C. (2007). Traditional and newer impulse controldisorders: a clinical update.. CLINICAL NEUROPSYCHIATRY, vol. 4, p. 30-38, ISSN: 1724-49352007 - Articolo in rivistaDell'Osso B., Mundo E., Buoli M, Hollander E., Altamura A.C. (2007). Obsessive- compulsive disorderand related disorders: clinical and biological updating and future indications.. MINERVAPSICHIATRICA, vol. 48, p. 195-210, ISSN: 1827-17312007 - Articolo in rivistaDell'Osso B., Buoli M, Ciabatti M., Altamura A.C. (2007). Disturbo ossessivo compulsivo e condizionicorrelate: inquadramento clinico e strategie di trattamento.. MEDICO E PAZIENTE, vol. 7, p. 22-27,ISSN: 0390-03472006 - Articolo in rivistaALTAMURA A.C., SANTINI A, MUNDO E (2006). Treatment issues in bipolar II depression.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, ISSN: 1461-14572006 - Articolo in rivistaMUNDO E, CATTANEO E, RUSSO M, ALTAMURA A.C. (2006). Clinical variables related toantidepressant-induced mania in bipolar disorder. JOURNAL OF AFFECTIVE DISORDERS, vol. 92(2-3),p. 227-230, ISSN: 0165-03272006 - Articolo in rivistaDELL'OSSO B, ALTAMURA A.C., ALLEN A, MARAZZITI D, HOLLANDER E (2006). Epidemiologic andclinical updates on impulse control disorders: a critical review. EUROPEAN ARCHIVES OF PSYCHIATRY

N. Progr. 8012

Pag. 11 di 27

120.

121.

122.

123.

124.

125.

126.

127.

128.

129.

130.

131.

132.

133.

134.

AND CLINICAL NEUROSCIENCE, vol. 256(8), p. 464-475, ISSN: 0940-13342006 - Articolo in rivistaDELL'OSSO B, MUNDO E, ALTAMURA A.C. (2006). Quetiapine augmentation of selective serotoninreuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up caseseries. CNS SPECTRUMS, ISSN: 1092-85292006 - Articolo in rivistaMUNDO E, CATTANEO E, ZANONI S, ALTAMURA A.C. (2006). The use of atypical antipsychoticsbeyond psychoses: efficacy of quetiapine in bipolar disorder. NEUROPSYCHIATRIC DISEASE ANDTREATMENT, vol. 2(2), p. 139-148, ISSN: 1176-63282005 - Articolo in rivistaMUNDO E, ALTAMURA A.C., VISMARA S, ZANARDINI R, BIGNOTTI S, RANDAZZO R, MONTRESOR C,GENNARELLI M (2005). MCP-1 gene (SCYA2) and schizophrenia: a case-control association study.AMERICAN JOURNAL OF MEDICAL GENETICS. PART B, NEUROPSYCHIATRIC GENETICS, vol. 132B(1),p. 1-4, ISSN: 1552-48412005 - Articolo in rivistaALTAMURA A.C., SANTINI A, SALVADORI D, MUNDO E (2005). Duration of untreated illness in panicdisorder: a poor outcome risk factor?. NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. 1(4), p.345-347, ISSN: 1176-63282005 - Articolo in rivistaDELL'OSSO B, ALTAMURA A.C., ALLEN A, HOLLANDER E (2005). Brain stimulation techniques in thetreatment of obsessive-compulsive disorder: current and future directions. CNS SPECTRUMS, ISSN:1092-85292005 - Articolo in rivistaLIEB R, BECKER E, ALTAMURA A.C. (2005). The epidemiology of generalized anxiety disorder inEurope. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 15(4), p. 445-452, ISSN: 0924-977X2005 - Articolo in rivistaALTAMURA A.C. (2005). The methodology of the studies in the treatment of maniac admissions.L'ENCÉPHALE, vol. 31(Pt 2), p. S42-S43, ISSN: 0013-70062005 - Articolo in rivistaAltamura A.C., Bassetti R, Cattaneo E, Vismara S. (2005). Some biological correlates of drugresistance in schizophrenia: a multidimensional approach.. THE WORLD JOURNAL OF BIOLOGICALPSYCHIATRY, vol. 6, p. 23-30, ISSN: 1562-29752004 - Articolo in rivistaALTAMURA A.C., BASSETTI R, SANTINI A, FRISONI GB, MUNDO E (2004). Emotional withdrawal, CTabnormalities and drug response in late life depression. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 28(2), p. 349-354, ISSN:0278-58462004 - Articolo in rivistaVAN OS J, ALTAMURA A.C., BOBES J, GERLACH J, HELLEWELL JS, KASPER S, NABER D, ROBERT P(2004). Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of amultinational, randomised controlled trial. BRITISH JOURNAL OF PSYCHIATRY, vol. 184, p. 79-83,ISSN: 0007-12502004 - Articolo in rivistaALTAMURA A.C., RUSSO M, VISMARA S, MUNDO E (2004). Comparative evaluation of olanzapineefficacy in the maintenance treatment of bipolar disorder. JOURNAL OF CLINICALPSYCHOPHARMACOLOGY, vol. 24(4), p. 454-456, ISSN: 0271-07492004 - Articolo in rivistaALTAMURA A.C., MONTRESOR C, SALVADORI D, MUNDO E (2004). Does comorbid subthresholdanxiety affect clinical presentation and treatment response in depression? A preliminary 12-monthnaturalistic study. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol. 7(4), p.481-487, ISSN: 1461-14572003 - Articolo in rivistaMELTZER HY, ALPHS L, GREEN AI, ALTAMURA A.C. (2003). CLOZAPINE TREATMENT FOR SUICIDALITYIN SCHIZOPHRENIA INTERNATIONAL SUICIDE PREVENTION TRIAL INTERSEPT. ARCHIVES OFGENERAL PSYCHIATRY, vol. 60 (1), p. 82-91, ISSN: 0003-990X2003 - Articolo in rivistaALTAMURA A.C., BASSETTI R, BIGNOTTI R, PIOLI R, MUNDO E. (2003). CLINICAL VARIABLES

N. Progr. 8012

Pag. 12 di 27

134.

135.

136.

137.

138.

139.

140.

141.

142.

143.

144.

145.

146.

147.

RELATED TO SUICIDE ATTEMPTS IN SCHIZOPHRENIC PATIENTS A RETROSPECTIVE STUDY.SCHIZOPHRENIA RESEARCH, vol. 60 (1), p. 47-55, ISSN: 0920-99642003 - Articolo in rivistaALTAMURA A.C., SASSELLA F, SANTINI A, MONTRESOR C, FUMAGALLI S, MUNDO E (2003).Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. DRUGS, vol.63(5), p. 493-512, ISSN: 0012-66672003 - Articolo in rivistaCARTA MG, ALTAMURA A.C., HARDOY MC, PINNA F, MEDDA S, DELL'OSSO L, CARPINIELLO B, ANGSTJ (2003). Is recurrent brief depression an expression of mood spectrum disorders in young people?Results of a large community sample. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICALNEUROSCIENCE, vol. 253(3), p. 149-153, ISSN: 0940-13342003 - Articolo in rivistaALTAMURA A.C., BASSETTI R, BOCCHIO L, SANTINI A, MUNDO E (2003). Season of birth andinflammatory response system in schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY &BIOLOGICAL PSYCHIATRY, vol. 27(5), p. 879-880, ISSN: 0278-58462003 - Articolo in rivistaALTAMURA A.C., SALVADORI D, MADARO D, SANTINI A, MUNDO E (2003). Efficacy and tolerability ofquetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-labelstudy. JOURNAL OF AFFECTIVE DISORDERS, vol. 76(1-3), p. 267-271, ISSN: 0165-03272003 - Articolo in rivistaALTAMURA A.C., DI ROSA A, ERMENTINI A, Guaraldi GP, INVERNIZZI G, RUDAS N, TACCHINI G,PIOLI R (2003). Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-overstudy. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol. 7, p. 155-159, ISSN:1365-15012003 - Articolo in rivistaALTAMURA A.C., RUSSO M, SALVATORI D (2003). La continuità terapeutica nel Disturbo Bipolare.Considerazioni sull'uso dell'olanzapina dalla mania al mantenimento. RIVISTA DI PSICHIATRIA, vol. 6,ISSN: 2038-25022003 - Articolo in rivistaAltamura A.C., Charitos S., Fusi O., Tacchini G. (2003). Disturbo somatico e funzionale e sindromimiste ansioso-depressive: aspetti clinico terapeutici.. QUADERNI ITALIANI DI PSICHIATRIA, vol. XXII,p. 33-50, ISSN: 0393-06452002 - Articolo in rivistaALTAMURA A.C., BOCCHIO CHIAVETTO L, GENNARELLI M, BASSETTI R, SANTINI A (2002). Somepsychoimmunological correlates in relation to drug response in schizophrenia. SCHIZOPHRENIARESEARCH, vol. 53 (3), p. 200, ISSN: 0920-99642002 - Articolo in rivistaMAES M, BOCCHIO CHIAVETTO L, BIGNOTTI S, BATTISA TURA GJ, PIOLI R, BOIN F, KENIS G,BOSMANS E, DE JONGH R, ALTAMURA A.C. (2002). Increased serum interleukin-8 and interleukin-10in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects ofclozapine on serum leukemia inhibitory factor receptor. SCHIZOPHRENIA RESEARCH, vol. 54(3), p.281-291, ISSN: 0920-99642002 - Articolo in rivistaVAN OS J, ALTAMURA A.C., BOBES J, OWENS DC, GERLACH J, HELLEWELL JS, KASPER S, NABER D,TARRIER N, ROBERT P (2002). 2-COM: an instrument to facilitate patient-professional communicationin routine clinical practice. ACTA PSYCHIATRICA SCANDINAVICA, vol. 106(6), p. 446-452, ISSN:0001-690X2002 - Articolo in rivistaCARPINIELLO B, BAITA A, CARTA MG, SITZIA R, MACCIARDI AM, MURGIA S, ALTAMURA A.C. (2002).Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia:results from a naturalistic follow-up study. EUROPEAN PSYCHIATRY, vol. 17(7), p. 394-398, ISSN:0924-93382002 - Articolo in rivistaALTAMURA A.C., VELONA I, CURRELI R, MUNDO E, BRAVI D. (2002). Is olanzapine better thanhaloperidol in resistant schizophrenia? A double-blind study in partial responders.. INTERNATIONALJOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, vol. 6, p. 107-111, ISSN: 1365-15012001 - Articolo in rivista

N. Progr. 8012

Pag. 13 di 27

147.

148.

149.

150.

151.

152.

153.

154.

155.

156.

157.

158.

159.

ALTAMURA A.C., PALUELLO MM, MUNDO E, MEDDA S, MANNU P (2001). Clinical and subclinical bodydysmorphic disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, vol.251(3), p. 105-108, ISSN: 0940-13342001 - Articolo in rivistaMAES M, DELMEIRE L, MYLLE J, ALTAMURA A.C. (2001). Risk and preventive factors of post-traumaticstress disorder (PTSD): alcohol consumption and intoxication prior to a traumatic event diminishes therelative risk to develop PTSD in response to that trauma. JOURNAL OF AFFECTIVE DISORDERS, vol.63(1-3), p. 113-121, ISSN: 0165-03272001 - Articolo in rivistaALTAMURA A.C., BASSETTI R, SASSELLA F, SALVADORI D, MUNDO E (2001). Duration of untreatedpsychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.SCHIZOPHRENIA RESEARCH, vol. 52(1-2), p. 29-36, ISSN: 0920-99642000 - Articolo in rivistaMAES M, BOCCHIO CHIAVETTO L, BIGNOTTI S, BATTISA TURA G, PIOLI R, BOIN F, KENIS G,BOSMANS E, DE JONGH R, LIN A, RACAGNI G, ALTAMURA A.C. (2000). Effects of atypicalantipsychotics on the inflammatory response system in schizophrenic patients resistant to treatmentwith typical neuroleptics. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 10(2), p. 119-124, ISSN:0924-977X2000 - Articolo in rivistaMAES M, MYLLE J, DELMEIRE L, ALTAMURA A.C. (2000). Psychiatric morbidity and comorbidityfollowing accidental man-made traumatic events: incidence and risk factors. EUROPEAN ARCHIVES OFPSYCHIATRY AND CLINICAL NEUROSCIENCE, vol. 250(3), p. 156-162, ISSN: 0940-13342000 - Articolo in rivistaALTAMURA A.C., BAREGGI SR (2000). Comment on 'reduced haloperidol does not interfere withantipsychotic activity of halperidol in the treatment of acute schizophrenia'. INTERNATIONAL CLINICALPSYCHOPHARMACOLOGY, vol. 15(5), p. 303-304, ISSN: 0268-13151999 - Articolo in rivistaALTAMURA A.C., VANGASTEL A, PIOLI R, MANNU P, MAES M (1999). Seasonal and circadian rhythmsin suicide in Cagliari, Italy. JOURNAL OF AFFECTIVE DISORDERS, vol. 53(1), p. 77-85, ISSN:0165-03271999 - Articolo in rivistaDE VOS N, SONG C, LIN A, DEMEDTS P, WAUTERS A, NEELS H, DE JONGH R, KENIS G, BOSMANS E,ALTAMURA A.C., MAES M (1999). Lower serum zinc in relation to serum albumin and proinflammatorycytokines in detoxified alcohol-dependent patients without apparent liver disease.NEUROPSYCHOBIOLOGY, vol. 39(3), p. 144-150, ISSN: 0302-282X1999 - Articolo in rivistaALTAMURA A.C., PIOLI R, VITTO M, MANNU P (1999). Venlafaxine in social phobia: a study inselective serotonin reuptake inhibitor non-responders. INTERNATIONAL CLINICALPSYCHOPHARMACOLOGY, vol. 14(4), p. 239-245, ISSN: 0268-13151999 - Articolo in rivistaALTAMURA A.C., BOIN F, MAES M (1999). HPA axis and cytokines dysregulation in schizophrenia:potential implications for the antipsychotic treatment. EUROPEAN NEUROPSYCHOPHARMACOLOGY,vol. 10(1), p. 1-4, ISSN: 0924-977X1999 - Articolo in rivistaPERCUDANI M, FATTORE G, GALLETTA J, MITA PL, CONTINI A, ALTAMURA A.C. (1999). Health carecosts of therapy-refractory schizophrenic patients treated with clozapine: a study in a communitypsychiatric service in Italy. ACTA PSYCHIATRICA SCANDINAVICA, vol. 99(4), p. 274-280, ISSN:0001-690X1998 - Articolo in rivistaLIN A, KENIS G, BIGNOTTI S, TURA GJ, DE JONG R, BOSMANS E, PIOLI R, ALTAMURA A.C., SCHARPÉS, MAES M (1998). The inflammatory response system in treatment-resistant schizophrenia:increased serum interleukin-6. SCHIZOPHRENIA RESEARCH, vol. 32(1), p. 9-15, ISSN: 0920-99641998 - Articolo in rivistaKANE JM, AGUGLIA E, ALTAMURA A.C., AYUSO GUTIERREZ JL, BRUNELLO N, FLEISCHHACKER WW,GAEBEL W, GERLACH J, GUELFI JD, KISSLING W, LAPIERRE YD, LINDSTRÖM E, MENDLEWICZ J,

N. Progr. 8012

Pag. 14 di 27

159.

160.

161.

162.

163.

164.

165.

166.

167.

168.

169.

170.

171.

172.

RACAGNI G, CARULLA LS, SCHOOLER NR (1998). Guidelines for depot antipsychotic treatment inschizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. EUROPEANNEUROPSYCHOPHARMACOLOGY, vol. 8(1), p. 55-56, ISSN: 0924-977X1998 - Articolo in rivistaALTAMURA A.C., BIGNOTTI S, TURA G, CURRELI R, PIOLI R (1998). Depressive symptomatologyduring clozapine treatment: two case reports. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 8(3),p. 239-240, ISSN: 0924-977X1998 - Articolo in rivistaALTAMURA A.C., CARTA MG, TACCHINI G, MUSAZZI A, PIOLI MR (1998). Prevalence of somatoformdisorders in a psychiatric population: an Italian nationwide survey. Italian Collaborative Group onSomatoform Disorders. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, vol.248(6), p. 267-271, ISSN: 0940-13341997 - Articolo in rivistaMAES M, VANDOOLAEGHE E, NEELS H, DEMEDTS P, WAUTERS A, MELTZER HY, ALTAMURA A.C.,DESNYDER R (1997). Lower serum zinc in major depression is a sensitive marker of treatmentresistance and of the immune/inflammatory response in that illness. BIOLOGICAL PSYCHIATRY, vol.42(5), p. 349-358, ISSN: 0006-32231996 - Articolo in rivistaALTAMURA A.C. (1996). HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN SCHIZOPHRENIA. BIOLOGICALPSYCHIATRY, vol. 40, p. 560-561, ISSN: 0006-32231996 - Articolo in rivistaALTAMURA A.C. (1996). Novel antipsychotics and the problem of clinical stabilization in schizophrenia:are they "stabilizer" rather than typical compounds?. INTERNATIONAL CLINICALPSYCHOPHARMACOLOGY, vol. 11(3), p. 153-155, ISSN: 0268-13151995 - Articolo in rivistaALTAMURA A.C., MAES M, DAI J, MELTZER HY (1995). Plasma concentrations of excitatory aminoacids, serine, glycine, taurine and histidine in major depression. EUROPEANNEUROPSYCHOPHARMACOLOGY, vol. 5, p. 71-75, ISSN: 0924-977X1995 - Articolo in rivistaALTAMURA A.C., TACCHINI GL, MAES M (1995). Haloperidol plasma 'threshold' levels for relapseprevention in schizophrenia: a study with haloperidol decanoate. EUROPEANNEUROPSYCHOPHARMACOLOGY, vol. 5 Suppl, p. 55-58, ISSN: 0924-977X1995 - Articolo in rivistaISAAC M, JANCA A, BURKE KC, COSTA E SILVA JA, ACUDA SW, ALTAMURA A.C., BURKE JD JR,CHANDRASHEKAR CR, MIRANDA CT, TACCHINI G (1995). Medically unexplained somatic symptoms indifferent cultures. A preliminary report from phase I of the World Health Organization InternationalStudy of Somatoform Disorders. PSYCHOTHERAPY AND PSYCHOSOMATICS, vol. 64(2), p. 88-93,ISSN: 0033-31901995 - Articolo in rivistaALTAMURA A.C., CARTA MG, CARPINIELLO B, PIRAS A, MACCIÒ MV, MARCIA L (1995). Lifetimeprevalence of brief recurrent depression (results from a community survey). EUROPEANNEUROPSYCHOPHARMACOLOGY, vol. 5 Suppl, p. 99-102, ISSN: 0924-977X1994 - Articolo in rivistaMAURI MC, LEVA P, COPPOLA MT, ALTAMURA A.C. (1994). L-sulpiride in young and elderly negativeschizophrenics: clinical and pharmacokinetic variables. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 18(2), p. 355-356, ISSN:0278-58461994 - Articolo in rivistaTACCHINI G, COPPOLA MT, MUSAZZI A, ALTAMURA A.C., INVERNIZZI G (1994). Multinationalvalidation of the Composite International Diagnostic Interview (CIDI). MINERVA PSICHIATRICA, vol.35(2), p. 63-80, ISSN: 0391-17721994 - Articolo in rivistaMAURI MC, VITA A, GIOBBIO GM, FERRARA A, DIECI M, BITETTO A, ALTAMURA A.C. (1994).Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological andclinical variables. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, vol. 9(1), p. 3-7, ISSN:0268-13151994 - Articolo in rivista

N. Progr. 8012

Pag. 15 di 27

172.

173.

174.

175.

176.

177.

178.

179.

180.

181.

182.

183.

184.

185.

186.

ALTAMURA A.C., MORO AR, PERCUDANI M (1994). Clinical pharmacokinetics of fluoxetine. CLINICALPHARMACOKINETICS, vol. 26(3), p. 201-214, ISSN: 0312-59631993 - Articolo in rivistaALTAMURA A.C., MAURI MC, FERRARA A, MORO AR, D'ANDREA G, ZAMBERLAN F (1993). Plasma andplatelet excitatory amino acids in psychiatric disorders. THE AMERICAN JOURNAL OF PSYCHIATRY, vol.150(11), p. 1731-1733, ISSN: 0002-953X1993 - Articolo in rivistaMAURI MC, GIANETTI S, PUGNETTI L, ALTAMURA A.C. (1993). Quazepam versus triazolam in patientswith sleep disorders: a double-blind study. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGYRESEARCH, vol. 13(3), p. 173-177, ISSN: 0251-16491993 - Articolo in rivistaALTAMURA A.C., PERCUDANI M (1993). The use of antidepressants for long-term treatment ofrecurrent depression: rationale, current methodologies, and future directions. JOURNAL OF CLINICALPSYCHIATRY, vol. 54 Suppl, p. 29-37, ISSN: 0160-66891992 - Articolo in rivistaALTAMURA A.C. (1992). A MULTIDIMENSIONAL (PHARMACOKINETIC AND CLINICAL-BIOLOGICAL)APPROACH TO NEUROLEPTIC RESPONSE IN SCHIZOPHRENIA. WITH PARTICULAR REFERENCE TODRUG RESISTANCE. SCHIZOPHRENIA RESEARCH, vol. 8, p. 187-198, ISSN: 0920-99641992 - Articolo in rivistaALTAMURA A.C. (1992). Relevance of pharmacokinetic studies on antipsychotics in the managementof schizophrenic disorders. CLINICAL NEUROPHARMACOLOGY, vol. 15(1), p. 243A-244A, ISSN:0362-56641991 - Articolo in rivistaALTAMURA A.C., MAURI MC, REGAZZETTI G, COPPOLA MT (1991). L-sulpiride in the treatment ofsomatoform disturbances: a double-blind study with racemic sulpiride. MINERVA PSICHIATRICA, vol.32(1), p. 25-29, ISSN: 0391-17721990 - Articolo in rivistaALTAMURA A.C., COLACURCIO F, MAURI MC, MORO AR, DE NOVELLIS F (1990). Haloperidoldecanoate in chronic schizophrenia: a study of 12 months with plasma levels. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 14(1), p. 25-35, ISSN: 0278-58461990 - Articolo in rivistaCANGER R, ALTAMURA A.C., BELVEDERE O, MONACO F, MONZA GC, MUSCAS GC, MUTANI R,PANETTA B, PISANI F, ZACCARA G, ET AL (1990). Conventional vs controlled-release carbamazepine:a multicentre, double-blind, cross-over study. ACTA NEUROLOGICA SCANDINAVICA, vol. 82(1), p.9-13, ISSN: 0001-63141990 - Articolo in rivistaALTAMURA A.C., REGAZZETTI MG, PORTA M (1990). Nimodipine in human alcohol withdrawalsyndrome--an open study. EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 1(1), p. 37-40, ISSN:0924-977X1990 - Articolo in rivistaALTAMURA A.C., MAURI MC, GIRARDI T, PANETTA B (1990). Clinical and toxicological profile offluphenazine decanoate in elderly chronic schizophrenia. INTERNATIONAL JOURNAL OF CLINICALPHARMACOLOGY RESEARCH, vol. 10(4), p. 223-228, ISSN: 0251-16491990 - Articolo in rivistaMAURI MC, PERCUDANI M, REGAZZETTI MG, ALTAMURA A.C. (1990). ALTERNATIVE PROPHYLACTICTREATMENTS TO LITHIUM IN BIPOLAR DISORDERS. CLINICAL NEUROPHARMACOLOGY, vol. 13(S1),p. 90-96, ISSN: 0362-56641990 - Articolo in rivistaBAREGGI SR, CAVALLARO R, PIROLA R, ALTAMURA A.C. (1990). Pharmacokinetics and adverse effectsof single doses of dothiepin in young and elderly subjects. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 14(2), p. 163-170, ISSN:0278-58461990 - Articolo in rivistaALTAMURA A.C., MAURI MC, GIRARDI T, PANETTA B (1990). Alcoholism and depression: a placebocontrolled study with viloxazine. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH,vol. 10(5), p. 293-298, ISSN: 0251-16491990 - Articolo in rivista

N. Progr. 8012

Pag. 16 di 27

186.

187.

188.

189.

190.

191.

192.

193.

194.

195.

196.

197.

198.

199.

200.

ALTAMURA A.C., CAVALLARO R, REGAZZETTI MG (1990). Prevalence and risk factors for tardivedyskinesia: a study in an Italian population of chronic schizophrenics. EUROPEAN ARCHIVES OFPSYCHIATRY AND CLINICAL NEUROSCIENCE, vol. 240(1), p. 9-12, ISSN: 0940-13341989 - Articolo in rivistaALTAMURA A.C., GUERCETTI G, PERCUDANI M (1989). Dexamethasone suppression test in positiveand negative schizophrenia. PSYCHIATRY RESEARCH, vol. 30(1), p. 69-75, ISSN: 0165-17811989 - Articolo in rivistaALTAMURA A.C., PERCUDANI M, GUERCETTI G, INVERNIZZI G (1989). Efficacy and tolerability offluoxetine in the elderly: a double-blind study versus amitryptiline. INTERNATIONAL CLINICALPSYCHOPHARMACOLOGY, vol. 4(S1), p. 103-106, ISSN: 0268-13151989 - Articolo in rivistaALTAMURA A.C., COLACURCIO F, MARINI S (1989). Ritanserin versus lorazepam: a double-blind,cross-over study of reaction times in healthy volunteers. INTERNATIONAL JOURNAL OF CLINICALPHARMACOLOGY RESEARCH, vol. 9(3), p. 197-201, ISSN: 0251-16491989 - Articolo in rivistaALTAMURA A.C., MAURI MC, RUDAS N, CARPINIELLO B, MONTANINI R, PERINI M, SCAPICCHIO PL,HADJCHRISTOS C, CARUCCI G, MINERVINI M, ET AL (1989). Clinical activity and tolerability oftrazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlledmulticenter trial. CLINICAL NEUROPHARMACOLOGY, vol. 12(S1), p. 25-37, ISSN: 0362-56641989 - Articolo in rivistaALTAMURA A.C., MAURI MC, DE NOVELLIS F, PERCUDANI M, VAMPINI V (1989). Residualneuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine.PHARMACOPSYCHIATRY, vol. 22(6), p. 246-249, ISSN: 0176-36791989 - Articolo in rivistaALTAMURA A.C., DE NOVELLIS F, GUERCETTI G, INVERNIZZI G, PERCUDANI M, MONTGOMERY SA(1989). Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, vol. 9(6), p. 391-396, ISSN:0251-16491989 - Articolo in rivistaALTAMURA A.C., COLACURCIO F, MAURI MC, DE VANNA M, RIGAMONTI R, MAJ M, VELTRO F,PANCHERI P, DELLE CHIAIE R, PORTA M, ET AL (1989). Controlled clinical study on the effect ofquazepam versus triazolam in patients with sleep disorders. MINERVA PSICHIATRICA, vol. 30(3), p.159-164, ISSN: 0391-17721989 - Articolo in rivistaALTAMURA A.C. (1989). Drug-resistance phenomena in major psychoses: their discrimination andcausal mechanisms. CLINICAL NEUROPHARMACOLOGY, vol. 13(S1), p. 1-5, ISSN: 0362-56641988 - Articolo in rivistaALTAMURA A.C., MONTGOMERY SA, WERNICKE JF (1988). The evidence for 20mg a day of fluoxetineas the optimal dose in the treatment of depression. THE BRITISH JOURNAL OF PSYCHIATRY.SUPPLEMENT, vol. 3, p. 109-112, ISSN: 0960-53711988 - Articolo in rivistaALTAMURA A.C., MAURI M, CAVALLARO R, COLACURCIO F, GORNI A, BAREGGI S (1988). Reducedhaloperidol/haloperidol ratio and clinical outcome in schizophrenia: preliminary evidences. PROGRESSIN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 12(5), p. 689-694, ISSN:0278-58461988 - Articolo in rivistaALTAMURA A.C., MAURI MC, COPPOLA MT, CAZZULLO CL (1988). Delusional AIDS and depression.BRITISH JOURNAL OF PSYCHIATRY, vol. 135, p. 267-269, ISSN: 0007-12501988 - Articolo in rivistaALTAMURA A.C., MAURI MC, COLACURCIO F, SCAPICCHIO PL, HADJCHRISTOS C, CARUCCI G,MINERVINI M, MONTANINI R, PERINI M, RUDAS N, ET AL (1988). Trazodone in late life depressivestates: a double-blind multicenter study versus amitriptyline and mianserin. PSYCHOPHARMACOLOGY,vol. 95(S), p. 34-36, ISSN: 0033-31581987 - Articolo in rivistaALTAMURA A.C., MAURI MC, GUERCETTI G, CAZZULLO CL (1987). Fluphenazine decanoate in acuteand maintenance therapy of schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY &BIOLOGICAL PSYCHIATRY, vol. 11(5), p. 613-623, ISSN: 0278-5846

N. Progr. 8012

Pag. 17 di 27

200.

201.

202.

203.

204.

205.

206.

207.

208.

209.

210.

211.

212.

213.

214.

1987 - Articolo in rivistaALTAMURA A.C., MAURI MC, CAVALLARO R, GORNI A (1987). Haloperidol metabolism andantipsychotic effect in schizophrenia. LANCET, vol. 1(8536), p. 814-815, ISSN: 0140-67361987 - Articolo in rivistaALTAMURA A.C., DE NOVELLIS F, MAURI MC, GOMENI R (1987). Plasma and brain pharmacokineticsof mianserin after single and multiple dosing in mice. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY& BIOLOGICAL PSYCHIATRY, vol. 11(1), p. 23-33, ISSN: 0278-58461987 - Articolo in rivistaALTAMURA A.C., MAURI MC, MANTERO M, BRUNETTI M (1987). Clonazepam/haloperidol combinationtherapy in schizophrenia: a double blind study. ACTA PSYCHIATRICA SCANDINAVICA, vol. 76(6), p.702-706, ISSN: 0001-690X1986 - Articolo in rivistaALTAMURA A.C., BUCCIO M, COLACURCIO F, COLOMBO G, TERZI A (1986). Orphenadrine plasmalevels and amelioration of extrapyramidal side effects in schizophrenic patients treated withhaloperidol. ACTA NEUROLOGICA, vol. 8(1), p. 19-26, ISSN: 0001-62761986 - Articolo in rivistaALTAMURA A.C., BUCCIO M, COLOMBO G, TERZI A, CAZZULLO CL (1986). Combination therapy withhaloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study. L'ENCÉPHALE,vol. 12(1), p. 31-36, ISSN: 0013-70061986 - Articolo in rivistaMASSERINI C, ROSINA E, MOROSINI F, ALTAMURA A.C., CAZZULLO CL, TORCELLO L (1986).Hyperbaric oxygen induced experimental epilepsy: the age factor. THE ITALIAN JOURNAL OFNEUROLOGICAL SCIENCES, vol. 7(3), p. 343-348, ISSN: 0392-04611986 - Articolo in rivistaALTAMURA A.C., MAURI M, GUERCETTI G (1986). Prophylactic treatment with mianserin, therapyadherence and plasma monitoring. A case report. ACTA PSYCHIATRICA SCANDINAVICA, vol. 74(2), p.220-221, ISSN: 0001-690X1986 - Articolo in rivistaALTAMURA A.C., MAURI MC, GUERCETTI G (1986). Age, therapeutic "milieu" and clinical outcome indepressive patients treated with viloxazine: a study with plasma levels. PROGRESS INNEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, vol. 10(1), p. 67-75, ISSN: 0278-58461986 - Articolo in rivistaALTAMURA A.C., BAREGGI SR, INVERNIZZI G, MORGANTI A, ZANCHETTI A (1986). The effects ofmianserin therapy on plasma renin activity in depressed patients. BIOLOGICAL PSYCHIATRY, vol.21(13), p. 1331-1334, ISSN: 0006-32231986 - Articolo in rivistaALTAMURA A.C., BASILE R, MAURI M, CAZZULLO CL (1986). Valpromide (Depamide) in the treatmentof acute psychotic states. Open clinical study. ACTA PSYCHIATRICA BELGICA, vol. 86(3), p. 297-304,ISSN: 0300-89671985 - Articolo in rivistaALTAMURA A.C., CURRY SH, MONTGOMERY S, WILES DH (1985). Early unwanted effects offluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.PSYCHOPHARMACOLOGY, vol. 87(1), p. 30-33, ISSN: 0033-31581985 - Articolo in rivistaALTAMURA A.C., MAURI M (1985). Plasma concentrations, information and therapy adherence duringlong-term treatment with antidepressants. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol.20(6), p. 714-716, ISSN: 0306-52511983 - Articolo in rivistaALTAMURA A.C., MELORIO T, INVERNIZZI G, COLACURCIO F, GOMENI R (1983). Age-relateddifferences in kinetics and side-effects of viloxazine in man and their clinical implications.PSYCHOPHARMACOLOGY, vol. 81(4), p. 281-285, ISSN: 0033-31581983 - Articolo in rivistaCORNAGGIA CM, ALTAMURA A.C., BIANCHI M, CANGER R, POLANA P, PRUNERI C (1983). PB:PRMratio in patients with epilepsy treated with primidone. INTERNATIONAL JOURNAL OF CLINICALPHARMACOLOGY RESEARCH, vol. 3(3), p. 185-193, ISSN: 0251-16491983 - Articolo in rivistaALTAMURA A.C., MELORIO T (1983). Mianserin metabolites. BRITISH JOURNAL OF CLINICAL

N. Progr. 8012

Pag. 18 di 27

214.

215.

216.

217.

218.

219.

220.

221.

222.

223.

224.

225.

226.

227.

228.

229.

230.

PHARMACOLOGY, vol. 16(2), p. 201-203, ISSN: 0306-52511982 - Articolo in rivistaALTAMURA A.C., BAREGGI SR, CORNAGGIA CM, GRIECO G, INVERNIZZI G, MELORIO T, ZECCA L(1982). Long-term treatment with mianserin: a clinical study with plasma levels. ADVANCES INBIOCHEMICAL PSYCHOPHARMACOLOGY, vol. 32, p. 357-361, ISSN: 0065-22291982 - Articolo in rivistaALTAMURA A.C., MELORIO T, INVERNIZZI G, GOMENI R (1982). Influence of age on mianserinpharmacokinetics. PSYCHOPHARMACOLOGY, vol. 78(4), p. 380-382, ISSN: 0033-31581981 - Articolo in rivistaHENRY JF, ALTAMURA A.C., GOMENI R, HERVY MP, FORETTE F, MORSELLI PL (1981).Pharmacokinetics of amitriptyline in the elderly. INTERNATIONAL JOURNAL OF CLINICALPHARMACOLOGY THERAPY AND TOXICOLOGY, vol. 19(1), p. 1-5, ISSN: 0174-48791981 - Articolo in rivistaCAZZULLO CL, ALTAMURA A.C., CORNAGGIA CM, CANGER R, PRUNERI C (1981). Therapeutic plasmalevels of some anticonvulsants in focal epilepsy in relation to computerized axial tomography.L'ENCÉPHALE, vol. 7(2), p. 191-197, ISSN: 0013-70061980 - Articolo in rivistaLOO H, BENYACOUB AK, ROVEI V, ALTAMURA A.C., VADROT M, MORSELLI PL (1980). Long-termmonitoring of tricyclic antidepressant plasma concentrations. BRITISH JOURNAL OF PSYCHIATRY, vol.137, p. 444-451, ISSN: 0007-12501979 - Articolo in rivistaALTAMURA A.C., WHELPTON R, CURRY SH (1979). Animal model for investigation of fluphenazinekinetics after administration of long-acting esters. BIOPHARMACEUTICS & DRUG DISPOSITION, vol.1(2), p. 65-72, ISSN: 0142-27821979 - Articolo in rivistaCURRY SH, ALTAMURA A.C., MONTGOMERY S (1979). Unwanted effects of fluphenazine enanthate anddecanoate. LANCET, vol. 1(8111), p. 331-332, ISSN: 0140-67361978 - Articolo in rivistaSACCHETTI E, SMERALDI E, BELLODI L, BOTTINELLI S, ALTAMURA A.C. (1978). Noxiptylin andmasked depression. AGRESSOLOGIE, vol. 19(1), p. 59-63, ISSN: 0002-11481978 - Articolo in rivistaALTAMURA A.C., BONATI M, BRUNELLO N, GIORDANO PL, ALGERI S (1978). The activity of someneurotransmitter-synthetizing enzymes in experimental cobalt epilepsy. NEUROSCIENCE LETTERS,vol. 7(1), p. 83-87, ISSN: 0304-39401978 - Articolo in rivistaALTAMURA A.C., ZANCHETTI A (1978). Renin and depression. BRITISH JOURNAL OF PSYCHIATRY, vol.132, p. 414, ISSN: 0007-12501977 - Articolo in rivistaALTAMURA A.C., GOMENI R, SACCHETTI E, SMERALDI E (1977). Plasma and intracellular kinetics oflithium after oral administration of various lithium salts. EUROPEAN JOURNAL OF CLINICALPHARMACOLOGY, vol. 12(1), p. 59-63, ISSN: 0031-69701977 - Articolo in rivistaALTAMURA A.C., MOROSINI F, GIORDANO PL (1977). Neurotransmitters and experimental epilepsy.Study of the activity of various enzymes involved in their synthesis in rats with cobalt powder-inducedepilepsy. ACTA NEUROLOGICA, vol. 32(5), p. 525-534, ISSN: 0001-62761977 - Articolo in rivistaALTAMURA A.C., MORGANTI A, SMERALDI E, ZANCHETTI A (1977). Plasma renin activity in primaryand secondary depression. ARCHIV FÜR PSYCHIATRIE UND NERVENKRANKHEITEN, vol. 224(4), p.313-318, ISSN: 0003-93731976 - Articolo in rivistaCAZZULLO CL, ALTAMURA A.C., CANGER R, PENATI G (1976). Cobalt-induced experimental epilepsyin cats pharmacologically immunodepressed. An EEG and histological study.ARZNEIMITTEL-FORSCHUNG, vol. 26(7), p. 1387-1393, ISSN: 0004-41721976 - Articolo in rivistaCAZZULLO CL, ALTAMURA A.C., SMERALDI E (1976). An immunological approach to the treatment ofepilepsy. AGRESSOLOGIE, vol. 17(4), p. 211-216, ISSN: 0002-11481975 - Articolo in rivista

N. Progr. 8012

Pag. 19 di 27

230.

231.

232.

233.

234.

SACCHETTI E, ALTAMURA A.C., SMERALDI E, ZIBETTI A (1975). N1-Methylnicotinamide urinaryoutput in multiple sclerosis affected patients. ACTA VITAMINOLOGICA ET ENZYMOLOGICA, vol.29(1-6), p. 206-209, ISSN: 0300-89241975 - Articolo in rivistaALTAMURA A.C., MORGANTI A (1975). Plasma renin activity in depressed patients treated withincreasing doses of lithium carbonate. PSYCHOPHARMACOLOGY, vol. 45(2), p. 171-175, ISSN:0033-31581975 - Articolo in rivistaALTAMURA A.C. (1975). Therapeutic attempts with lithium in young drug addicts. ACTAPSYCHIATRICA SCANDINAVICA, vol. 52(5), p. 312-319, ISSN: 0001-690X1974 - Articolo in rivistaALTAMURA A.C., GIORDANO PL (1974). Neurochemical, immunological and ultrastructural aspects ofexperimental epilepsy. Critical review of current data. ACTA NEUROLOGICA, vol. 29(1), p. 13-32,ISSN: 0001-62761974 - Articolo in rivistaALTAMURA A.C., CANGER R, GIORDANO F, PENATI G (1974). Pathogenetic considerations on themethod of development of experimental co-induced epilepsy based on ultrastructural data. ACTANEUROLOGICA, vol. 29(3), p. 284-292, ISSN: 0001-6276

Titoli

responsabilità scientifica per progetti di ricerca internazionali e nazionali, ammessi alfinanziamento sulla base di bandi competitivi che prevedano la revisione tra pari

Progetto Durata Ruolo Ricoperto

Ravizza Luigi Coordinatore scientifico, - da: 01/05/1996 Università degliStudi di CAGLIARI, protocollo 9606318985_006, area 06, titolo:Caratteristiche cliniche e risposta al trattamento della depressione maggiorenell'anziano, Cofinanziamento MIUR assegnato all'unità di ricerca :516 Euro,

12 Responsabilescientifico

da: 01/05/1994 , Ateneo/Ente Università degli Studi di CAGLIARI, Protocollo9506312570_004,Area 06 ,Titolo Caratteristiche cliniche e biologiche,aspetti epidemiologici della depressione maggioredell'anziano,Cofinanziamento MIUR assegnato 1.291 Euro


European and South AfricanJOINT EUROPEAN AND SOUTH AFRICANResearch Network in Anxiety Disorders (EUSARNAD) presentato sul bando"FP7-PEOPLE-2010-IRSES Research Executive Agency The Communityfinancial contribution 8400 Maximum Financial EC contribution: 289800€Proposal No 269213 - Acronym: EUSARNAD

24 Investigator

Network Italiano per la ricerca sulle psicosi- – STUDIO MULTICENTRICO SUIFATTORI CHE CONDIZIONANO IL FUNZIONAMENTO SOCIALE NELLA VITAREALE DELLE PERSONE CON DIAGNOSI DI SCHIZOFRENIA


Indici Neuropsicologici e Trattamenti Innovativi per le Psicosi Maggiori(neuroINNO) 50000 euro


L'influenza dell'età e del profilo genetico sulla presentazione clinica deiDisturbi dell'Umore e Neurodegenerativi. Studio su soggetti affetti daDisturbo Bipolare, Variante Comportamentale della DemenzaFrontotemporale e Morbo di Alzheimer confrontati con controlli sani.PUR90% Totale fondi assegnati 11.899,9


direzione di riviste, collane editoriali, enciclopedie e trattati di riconosciuto prestigio

N. Progr. 8012

Pag. 20 di 27

Tipo Titolo Dal Al

Trattati Fondamenti di Psichiatria e Psicofarmacologia Clinica Pensiero Scientifico Editore 2009

Trattati Argomenti di Clinica e Farmacoterapia delle Psicosi Maggiori, McGraw-Hill 1996

Trattati Il trattamento della Schizofrenia negli anni 2000, Il Pensiero Scientifico Editore 2002

Trattati Ansia Generalizzata e Comorbidità con i Disturbi dell’Umore Pacini Editore 2003

partecipazione a comitati editoriali di riviste, collane editoriali, enciclopedie e trattati diriconosciuto prestigio

Tipo Titolo Dal Al

Trattati Trattato Italiano di Psichiatria ( Coordinatori P.Pancheri, G.B.Cassano)Masson (1999)

1999

Trattati -Medicina Legale in Psichiatria (F.De Ferrari, A.C.Altamura),Mediserve 2001

Trattati -Le Forme Depressive (A.C. Altamura, A. Ceralli, M. Russo), Il PensieroScientifico Editore

2005

Trattati Manuale di Terapia Psichiatrica Integrata ( A.C.Altamura, F.Bogetto,M.Casacchia,G.Muscettola, M Maj) Pensiero Scientifico Editore

2011

Trattati Psichiatria (Carlo Lorenzo Cazzullo) Micarelli Editore 1993

Trattati Trattato di Psicofarmacologia Clinica (Curatori M.Balestrieri e C.Bellantuono)Pensiero Scientifico Editore

02/2003

Trattati il punto su: Farmacoterapia del Disturbo schizofrenico :Tattica e Strategia(Presentazione Paolo Pancheri) Scientific Press

1996

Trattati Psicofarmacoterapia clinica ( a cura D.Marazziti), G.Fioriti Editore 2003

Riviste International Clinical Psychopharmacology, Wolters kluver LippincottWilliams & Wilkins

1994

Riviste Journal of Affective Disorders , Elsevier 2000

Riviste The World Journal of Biological Psychiatry, Informahealthcare 2005

Riviste European Archives of Psychiatry and Clinical Neuroscience, Springer 1998

Riviste International Journal of Psychiatry in Clinical Practice, Informahealthcare 2000

Riviste Neuropsychiatry , Future Medicine 05/2010 2012

Riviste Open Journal of Psychiatry (OJPsych), Scientific Research Publishing (SCIRP) 05/2011 2012

Riviste Epidemiology and Psychiatric Sciences, Cambridge University Press 2012 2012

Riviste European Neuropsychopharmacology, Elsevier 12/2009

Riviste Journal of Forensic Psychiatry & Psychology Routledge Taylor &Francis Group 1998

Riviste Italian Journal of Psychiatry and Behavioural Science 1994 2012

Riviste International Journal of Neuropsychopharmacology, Cambridge UniversityPress

2006

N. Progr. 8012

Pag. 21 di 27

Riviste Noos, aggiornamenti in Psichiatria, Il Pensiero Scientifico Editore 2003

Riviste Giornale Italiano di Psicopatologia, Pacini Editore 2003

Riviste Rivista Italiana di Psichiatria, Il Pensiero Scientifico Editore 1998

Riviste

attribuzione di incarichi di insegnamento o di ricerca ( ) ufficiale presso atenei e istitutifellowshipdi ricerca, esteri e internazionali, di alta qualificazione

Tipo Ente Dal Al

Insegnamento Invited Lecture all'ECNP School of Neuropsychopharmacology, 8-13July 2012, Oxford, United Kingdom.

07/2012

Insegnamento Co-Chair e relatore al 10th World Congress of Biological PsychiatryPraga

05/2011 06/2011

Insegnamento Chairman e relatore Simposi al 22nd European College ofNeuroPsychopharmacology - ECNP" - Istanbul,

09/2009

Insegnamento Relatore "Key Diagnostic Issues in GAD" al MAP-Managing Anxiety inPractice-A pan European Working Group for Generalized AnxietyDisorder - The Haghee

12/2009

Insegnamento Relatore al congresso EPA con relazione "comorbidity in majorpsychoses"

01/2009

Insegnamento Invited Lecture su " Long Term treatment goals in Schizophrenia, 9°International Psychiatry Forum Mind Matters, Praga

6/2008

Insegnamento nvited Lecturer : Biennial CINP Congress : " HPA Axis, immunesystem and antypsichotic response in Schizophrenia . Chicago

7/2006

Insegnamento 6°International Psychiatry Forum Mind Matters. InvitedLecturer:"Antidepressant use in BPD: limitations and perspective" e "Drug abuse in Schizophrenia : cause or Consequence?", Atene,Grecia

06/2005

Insegnamento Chairman :'European Think Tank Group su: " Schizophrenia:diagnosisand continuing care .Principles of Practice in the era of nrwgenaration antipsychotics. Barcellona ,Spagna

03/2000

Insegnamento Invited lecture :Principles of practice : a new philosophy of care.Seventeenth Annual Pittsburgh Schizophrenia ConferenceWesternPsychiatric Institute and Clinic, Schizophrenia Treatment andResearch Center and the University of Pittsburgh School of Medicine,Center for Continuing Education in the Health Sciences.

12/2000

Insegnamentoe Ricerca

Partecipazione al " WHO International Study of SomatoformDisorders"

1995


"Visiting Professor", presso il Laboratorio di Psicobiologiadell'Università di Cleveland (USA), Dipartimento di Psichiatria direttodal Prof. H. Meltzer, argomento: ricerche su clozapina ed aminoacidieccitatori cerebrali

09/1993 12/1993

Insegnamento Laboratorio di Psichiatria Biologica , Dipartimento di Psichiatria , CaseWestern Reserve University school of medicine , (Prof.H.Y.Meltzer)

01/1993 01/1994

N. Progr. 8012

Pag. 22 di 27

Insegnamento "Visiting Professor for lecturing" presso il Dipartimento di Psichiatriadell'Universita' di Iowa City (Prof. N. Andreasen)

07/1987


"Visiting Professor for lecturing" presso il Dipartimento di Psichiatriadell'Universita'di Pittsburg (Prof. D. Van Kammen)

07/1987

Ricerca Principale investigatore del "WHO Collaborating Center for Researchand Training in Mental Health , responsabile Prof.C .L.Cazzullo conseguenti tematiche: C.I.D.I. ( Composite International DiagnosticInterview) , drug abuse, disturbi somatoformi.

10/1987 1992

Ricerca Attività di ricerca presso Laboratoires d’Etudes et RecherchesSynthelabo, Paris

09/1978 04/1979

Ricerca Attività di ricerca presso London Hospital Medical College 02/1978 09/1978

Ricerca Laboratorio di Farmacologia Clinica dell'Istituto di RicerchrFarmacologiche " Mario Negri" Milano

06/1975 01/1976

Ricerca Attività di ricerca presso l'Unita' di Psicofarmacologia dell'Universita'di Aarhus (DK)

08/1974 08/1974

direzione di enti o istituti di ricerca di alta qualificazione internazionale

Ente Dal Al

Membro del Comitato Esecutivo dell' European College of Neuropsycopharmacology (ECNP) 1998 2002

Membro del Comitato Esecutivo del Collegium Internationale NeuroPsycopharmachologicum(CINP)

2002 2006

Membro del ECNP Nominating Committee 2007 2010

Councilor del Collegium Internationale NeuroPsycopharmachologicum (CINP) 2002 2004

Membro Regional Committee (Committee Treasurer) del Collegium InternationaleNeuroPsycopharmachologicum (CINP)

2006 2008

Councilor dell'International Society for Bipolar Disorders (ISBD) 2010

Presidente eletto della Societa Italiana di Psicopatologia (SOPSI) 2012

Presidente eletto della Societa italiana di Neuropsicofarmacologia (SINPF) 2010

Presidente e Fondatore di “Innovazione in Psichiatria” (INNOPSY), Forum Internazionalebiennale ,che a partire dal 2005 riunisce a Milano personalità prestigiose in campointernazionale in ambito psichiatrico

2005

partecipazione ad accademie aventi prestigio nel settore

Accademia Dal Al

Partecipazione al Delphi Panel di "Grand Challenges in Global Mental Health Initiative"condotta da " the U.S. National Institute of Mental Health " the Global Alliance for ChronicDisease, in partecipazione con the Wellcome Trust, the McLaughlin-Rotman Centre for GlobalHealth, and the London School of Hygiene and Tropical Medicine.

2011

conseguimento di premi e riconoscimenti per l'attività scientifica

N. Progr. 8012

Pag. 23 di 27

• E’ Presidente e Fondatore di “Innovazione in Psichiatria” (INNOPSY), Forum Internazionale biennale ,che apartire dal 2005 riunisce a Milano personalità prestigiose in campo internazionale in ambito psichiatrico.Nel2009 ha ricevuto il premio :Ambasciatore della Città di Milano" per il suo personale impegno ad aggiudicarea Milano il Congresso INNOPSY 2009 ,15 maggio 2009 ,Palazzo Marino.• Ha ricevuto dei riconoscimenti scientifici da parte dell’ “European Science Foundation Training Programmein Brain and Behaviour Research” (Strasbourg) (1978) e per l’ “Operosita' Scientifica” dall'Universita' degliStudi di Milano (Anno Accademico 1980-81).. Ha ricevuto la richiesta di commemorare la figura di Camillo Golgi da parte dell'American Journal Psychiatrycon un articolo pubblicato nell'aprile 1996 a 70 anni dalla morte.• In riconoscimento della ragguardevole attività di ricerca svolta, il suo nominativo è stato selezionato dal1997 nel “Who’s Who”(Science and Engineering)• 2003 Membro della Commissione per l’assegnazione del “Interbrew -Baillet Latour Health Prize” 2003 perlo studio dei Disturbi Schizofrenici , assegnato alla Prof.ssa Nancy C. Andreasen,(Bruxelles)• 2011:Membro della Commissione di Valutazione per l’Agence Nationale de la Recherche(ANR) Parigi• -2012 Reviewer per Progetti di Ricerca per la Slovenian Research Agency

altri titoli

• E’ Co- Autore di “Consensus Statements” e delle Linee Guida per:-ECNP (Guidelines for Depot Antipsychotic Treatment in Schizophrenia [Kane et al., EurNeuropsychopharmacol. 1998;8(1):55-66],-WPA (WPA Section on Pharmacopsychiatry: SSRIs/Antidepressants and Suicide Risk [Moeller et al., EurArch Psychiatry Clin Neurosci. 258 Suppl 3:3-23. 2008]; Comparative Effectiveness of Antipsychotics in theTreatment of Schizophrenia [Tandon et al., Schizophr Res. 2008;100(1-3):20-38])-WFSBP (Guidelines for the Treatment of Schizophrenia [Falkai et al., 2005 World J Biol Psychiatry.2005;6(3):132-91]).Membro del Comitato Scientifico della "Romanian Psychopharmacology Association" (22-6-2007)

-Ha ricevuto da parte dell'American Psychiatric Association la richiesta di partecipazione ad un panelinternazionale per l’elaborazione di Linee Guida Americane di Pratica Psichiatrica .( aprile 2012)-

• E’ membro di diverse Società Professionali quali :

- World Psychiatric Association (Member of the Section of Pharmacotherapy);- World Federation Societies of Biological Psychiatry (WFSBP).gg- Società Italiane di Psichiatria, Psicopatologia (Presidente eletto), Psichiatria Biologica,Neuro-Psicofarmacologia (Presidente eletto), Neuroscienze e Psicogeriatria.

Direttore della Scuola di Specializzazione in Psichiatria ,Università degli studi di Milano, dal 2005 a marzo2009.

Ha in atto numerose collaborazioni internazionali:

Paese Straniero Città Referente Argomento Anno1.Stati Uniti Nashville Prof HY Meltzer/Vanderbilt Univ. Schizofrenia 2003-In corsoPubblicazioni:1: Altamura AC, Bobo WV, Meltzer HY. Factors affecting outcome in schizophrenia and their relevance forpsychopharmacological treatment. Int Clin Psychopharmacol. 2007 ;22(5):249-67.

2: Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M,Chouinard G, Islam MZ,Kane J, Krishnan R, Lindenmayer JP, Potkin S;International Suicide Prevention Trial Study Group. Clozapinetreatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).Arch GenPsychiatry. 2003 ; 60(1):82-913: Altamura AC, Mundo E, Bassetti R, Green A, Lindenmayer JP, Alphs L, Meltzer HY. Transculturaldifferences in suicide attempters: analysis on a high-risk population of patients with schizophrenia orschizoaffective disorder . Schizophr Res. 2007 ; 89(1-3):140-6.

N. Progr. 8012

Pag. 24 di 27

2.Stati Uniti New York Prof E Hollander/Mt Sinai School of Medicine Disturbi Ossessivi 2005-In corsoPubblicazioni:1: Dell'Osso B, Allen A, Altamura AC, Buoli M, Hollander E. Impulsive-compulsive buying disorder: clinicaloverview. Aust N Z J Psychiatry. 2008 ;42(4):259-66.

2: Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E. Diagnosis and treatment ofobsessive-compulsive disorder and related disorders. Int J Clin Pract. 2007 ;61(1):98-104.

3: Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulsecontrol disorders: a critical review. Eur Arch Psychiatry Clin Neurosci. 2006;256(8):464-75.

4: Dell'Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment ofobsessive-compulsive disorder: current and future directions.CNS Spectr. 2005; 10(12):966-79, 983.

3.Svizzera Zurigo Prof J.Angst/Univ. Psychiatric Hospital Disturbi dell’Umore 2007-In corsoPubblicazioni:1: Angst J, Gamma A, Pezawas L, Ajdacic-Gross V, Eich D, Rössler W, Altamura C. Parsing the clinicalphenotype of depression: the need to integrate brief depressive episodes. Acta Psychiatr Scand.2007;115(3):221-8.2.Altamura AC, Buoli M, Dell'osso B, Albano A, Serati M, Colombo F, Pozzoli S, Angst J.The impact of briefdepressive episodes on the outcome of bipolar disorder and major depressive disorder: a 1-year prospectivestudy.J Affect Disord. 2011 Nov;134(1-3):133-7

4.Multisites collaboration (Vienna,Copenhagen,Nice etc) Psicofarmacologia 2004-In corsoPubblicazioni:1: Robert PH, Michel E, Van Os J, Altamura AC, Bobes J, Gerlach J, Hellewell JS, Kasper S, Nabel D. [2-COM:presentation of an instrument facilitating communication between physicians and carers in daily practice].Encephale. 2007 ;33(1):60-4.

2: Van Os J, Altamura AC, Bobes J, Gerlach J, Hellewell JS, Kasper S, Naber D,Robert P. Evaluation of theTwo-Way Communication Checklist as a clinical intervention. Results of a multinational, randomisedcontrolled trial. Br J Psychiatry. 2004;184:79-83.

Multicenter Collaborative :-Group WHO:1 . Cottler LB, Robins LN, Babor T, Helzer J, Towle L, Grant B, Blaine J, Wittchen HU, Sartorius J, Burke J,Regier D, Tipp J, Altamura AC et al: Cross-cultural reli-ability and acceptability of the CIDI-core substanceabuse and dependence ques-tions. In: Psychiatry: A world Perspective, CN Stefanis et al (Eds) ElsevierNorth Holland, Amsterdam Vol.1 , 144-152. (1990).2. Wittchen HU, Robins LN, Cottler L., Sartorius N., Burke J., Regier D., Alta-mura AC, et al: Inter-raterreliability of the Composite International Diagnostic In-terview (CIDI)-results of the multicenterWho/Adamha field trials (WAVE I ) In: Psychiatry: world Perspective, C.N. Stefanis et al (Eds) Elsevier NorthHolland Am-sterdam, Vol 1, 125- 132. (1990).3. Wittchen H.U., Robins L.N., Cottler L.B., Sartorius N., Altamura AC.: Cross-cultural feasibility, reliabilityand sources of variance of the Composite International Diagnostic Interview (CIDI). British Journal ofPsychiatry, 159, 645-653. (1991).

-European Expert Panel :1. Altamura AC, Bobes J, Cunningham Owens D, Gerllach J, Hellewell J, Kasper S, Naber D, Tarrier N, VanOs J. Schizophrenia: diagnosis and continuing treatment. Principles of practice from the European ExpertPanel on the Contemporary Treat-ment of Schizophrenia. International Journal of Psychiatry in ClinicalPractice 4 (Suppl.1): 1-11. (2000).2. Van Os J, Altamura AC, Bobes J, Kasper S, Naber D, Robert P, et al. Evalua-tion of the Two-WayCommunication Checklist as a clinical intervention. Results of a multinational, randomised controlled trial.British Journal of Psychiatry; 184: 79-83. (2004).3. Van Os J, Altamura AC, Bobes J, Owens DC, et al. 2-COM : an instrument to facilitate patient-professionalcommunication in routine clinical practice. Acta Psychiatrica Scandinava 106: 446-452. (2002).

N. Progr. 8012

Pag. 25 di 27

4. Lieb R, Becker E, Altamura AC. The Epidemiology of Generalized Anxiety Disorder in Europe. EuropeanNeuropsychopharmacology, 15 (4): 445-452 (2005)

5. Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP. Im-portance of open access toatypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.Current Medical Research and Opin-ion 2008, Curr Med Res Opin .2008;24(8):2271-82

5.Germania Monaco Prof HJ Moller/Ludwig-Maximilians-Univ. Schizofrenia 2008-In corsoPubblicazioni:1:Möller HJ, Malt U, Saletu B, Altamura AC, Baldwin DS, Baron D, Bauer M, Belmaker RH, Blier P, Boyer P,Bunney WE, Burrows G, Fleischhacker W, Flores D, Gattaz WF, Goodwin G, Heinze G, Hindmarch I, HippiusH, Hoschl C, Kasper S, Kragh-Sorensen P, Lopez-Ibor JJ, Malt U, Millet B, Min SK, Monti J,Muller-Oer-linghausen B, Muller-Spahn F, Nutt DJ, Okasha A, Olie JP, Paykel ES, Racagni G, Renshaw P,Rosenberg R, Singh B, Stein DJ, Tandon R, Versiani M, Vieta E, Zohar J. WPA Section onPharmacopsychiatry. Do SSRIs or antidepressants in general increase suicidality? WPA Section onPharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008;258 Suppl 3:3-23.

2: Altamura AC, Baldwin DS, Baron D, Bauer M, Belmaker RH, Blier P, Boyer P, Bunney WE, Burrows G,Fleischhacker W, Flores D, Gattaz WF, Goodwin G, Heinze G, Hindmarch I, Hippius H, Hoschl C, Kasper S,Kragh-Sorensen P, Lopez-Ibor JJ, Malt U, Millet B, Min SK, Moeller HJ, Monti J, Muller-Oerlinghausen B,Muller-Spahn F, Nutt DJ, Okasha A, Olie JP, Paykel ES, Racagni G, Renshaw P, Rosenberg R, Saletu B, SinghB, Stein DJ, Tandon R, Versiani M, Vieta E, Zohar J.; Section of Pharmacopsychiatry, World PsychiatricAssociation. World Psychiatric Association Pharmacopsychiatry Section statement on comparativeeffectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res. 2008;100 (1-3):20-38.

6.U.K. Southampton Prof DS Baldwin/Univ. of Southampton Disturbi D’Ansia 2008-In corsoPubblicazioni:1:Möller HJ, Malt U, Saletu B, Altamura AC, Baldwin DS, Baron D, Bauer M, Belmaker RH, Blier P, Boyer P,Bunney WE, Burrows G, Fleischhacker W, Flores D, Gattaz WF, Goodwin G, Heinze G, Hindmarch I, HippiusH, Hoschl C, Kasper S, Kragh-Sorensen P, Lopez-Ibor JJ, Malt U, Millet B, Min SK, Monti J,Muller-Oer-linghausen B, Muller-Spahn F, Nutt DJ, Okasha A, Olie JP, Paykel ES, Racagni G, Renshaw P,Rosenberg R, Singh B, Stein DJ, Tandon R, Versiani M, Vieta E, Zohar J. WPA Section onPharmacopsychiatry. Do SSRIs or antidepressants in general increase suicidality? WPA Section onPharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008;258 Suppl 3:3-23.

2: Altamura AC, Baldwin DS, Baron D, Bauer M, Belmaker RH, Blier P, Boyer P, Bunney WE, Burrows G,Fleischhacker W, Flores D, Gattaz WF, Goodwin G, Heinze G, Hindmarch I, Hippius H, Hoschl C, Kasper S,Kragh-Sorensen P, Lopez-Ibor JJ, Malt U, Millet B, Min SK, Moeller HJ, Monti J, Muller-Oerlinghausen B,Muller-Spahn F, Nutt DJ, Okasha A, Olie JP, Paykel ES, Racagni G, Renshaw P, Rosenberg R, Saletu B, SinghB, Stein DJ, Tandon R, Versiani M, Vieta E, Zohar J.; Section of Pharmacopsychiatry, World PsychiatricAssociation. World Psychiatric Association Pharmacopsychiatry Section statement on comparativeeffectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res. 2008 ;100 (1-3):20-38.

3.Dell'Osso B, Glick ID, Baldwin DS, Altamura AC. . Can Long-Term Outcomes Be Improved by Shorteningthe Duration of Untreated Illness in Psychiatric Disorders A Conceptual Framework. Psychopathology. 2012Aug 7. [Epub ahead of print]4.Progetto multicentrico europeo ECNP per lo studio dei disturbi d’Ansia IADRN (International AnxietyDisorders Research Network)

N. Progr. 8012

Pag. 26 di 27

7.Francia Parigi Hospital Sainte-Anne Disturbi Depressivi 2008 - In corsoPubblicazioni:

1. Loo H, Benyacub K, Rovei V, Altamura AC, Vadrot M, Morselli PL: Long-term monitoring of tricyclicantidepressants plasma concentrations. British Journal of Psychiatry, 137, 444-451. (1980).

2. Henry JF, Hrdina PD, Altamura AC, Rovei V, Gomeni R et al.: Pharmacocinetique de l'amitriptyline (AMI),l'imipramine (IMI) et la maprotiline (MAP) chez le sujet age. Psycol. Med. 12, 2389-2394. (1980).3. Lepine JP, Altamura AC, Ansseau M, Waintraub L. Tianeptina and paroxetine in major depressive disorder,with a special focus on the anxious component in de-pression: an international, 6-week double.blind study.Human Psychopharmacology; 16: 219-227. (2001).

8.Stati Uniti Prof I Glick/Stanford University Schizofrenia 2009-In corsoPubblicazioni:1. Designing Outcome Studies to Determine Efficacy and Safety of Antipsychotics for “Real World” Treatmentof Schizophrenia. IJNP, in press2.Glick ID, Correl CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, Leucht S, Davis JM. Mid-termand long-term efficacy and effectiveness of antipsy-chotic medications for schiiizophrenia: a data-driven,personalized clinical approach. J Clin Psychiatry. 72(12) :1616-27 (2011)

9 U.K. Prof.Guy Goodwin University of Oxford Warneford Hospital Oxford Neuro Psicofarmacologia1 Altamura AC e Goodwin GM How Law 180 in Italy has reshaped psychiatry after 30 years: past attitudes,current trends and unmet needs... Br J Psychiatry. (2010)2 Goodwin GM, Abbar M, Schlaepfer TE, Grunze H, Licht RW, Bellivier F, Fountoulakis KN, Altamura AC,Pitchot W, Agren H, Holsboer-Trachsler E, Vieta E. Aripiprazole in patients with bipolar mania and beyond:an update of pratical guidance. Curr Med Res Opin. 27(12):2285-99 (2011)10 Thailand. Prof Michael.Maes Chulalongkorn University Bangkok Depressione ,Schizofrenia1. Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M,Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drugstarget in depression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol boil Psychiatry. Apr29;35(3):659-63. (2011)2. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment withneuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Maes M,Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, AltamuraCA. Schizophr Res. 2002 Apr 1;54(3):281-91.3. Maes M, DeVos N, Wauters A, Demedts P, Mauritis VW, Neels H, Bosmans E, Altamura AC, Lin A, Song C,Vandenbroucke M, Scharpe S. Inflammatory mar-kers in younger vs elderly normal volunteers and inpatients with Alzheimer’s disea-se. Journal of Psychiatry Research 33 (5): 397-405. (1999).4. Maes M, Christophe A, Delanghe J, Altamura AC, Neels H, Meltzer HY. Low-ered omega3 polyunsaturatedfatty acids in serum phospholipids and cholesteryl es-ters of depressed patients. Psychiatry Research 85 (3):275-291. (1999).5. De Vos N, Song C, Lin A, Demedts P, Wauters A, Neels H, De Jongh R, Kenis G, Bosmans E, Altamura AC,Maes M. Lower serum zinc in relation to serum al-bumin and proinflammatory cytokines in detoxifiedalcohol-dependent patients without apparent liver disease. Neuropsychobiology 39 (3): 144 – 150. (1999).6. Maes M, Mylle M, Delmeire L, Altamura AC. Psychiatric morbidity and co-morbidity following accidentalman-made traumatic events: incidence and risk fac-tors. European Archives of Psychiatry & ClinicalNeuroscience 250 (3): 156-162. (2000).7. Altamura AC, VanGastel A, Pioli R, Mannu P, Maes M. Seasonal and circadian rythms in suicide in Cagliari,Italy. Journal of Affective Disorders 53: 77-85. (1999).8. Lin A, Kenis G, Bignotti S, Tura GB, De Jong R, Bosmans E, Pioli R, Altamura AC, Scharpè S, Maes M. Theinflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.Schizophrenia Research 32: 9-15. (1998).9. Altamura AC, Boin F, Maes M. HPA axis and cytokines dysregulation in schizophrenia: potentialimplications for the antipsychotic treatment. European Neu-ropsychopharmacology 10: 1-4. (1999).10. Maes M, Meltzer HY, Altamura AC et al. Lower serum zinc in major depression is a sensitive marker oftreatment resistance and of the immune/inflammatory response in that illness. Biological Psychiatry 42:

N. Progr. 8012

28/08/2012 15:00 Pag. 27 di 27

349-358 (1997).11. Maes M, Vandoolaeghe E, Degroote J, Altamura AC, Roels C, Hermans P. Linear CT-scan measurementsin alcohol-dependent patients with and without delir-ium tremens. Alcohol 20 (2): 117-123. (2000).12. Maes M, Libbrecht I, Lin A, Goossens F, Ombelet W, Stevens K, Bosmans E, Altamura AC, Cox J, deJongh R, Scharpe S. Effects of pregnacy and delivery on serum prolyl endopeptidase (PEP) activity:alterations in serum PEP are related to increased anxiety in the puerperium and to postpartum depression.Journal of Affec-tive Disorders 57: 125-137. (2000).13. Boin F, Zanardini R, Pioli R, Altamura AC, Maes M, Gennarelli M. Associa-tion between G308A tumornecrosis factor alpha gene polymorphism and schizo-phrenia. Molecular Psychiatry 6 (1): 79-82. (2001).14.Maes M, Delmeire L, Mylle J, Altamura AC. Risk and preventive factors of post-traumatic stress disorder(PTSD): consumption and intoxication prior to a traumatic event diminished the relative risk to developPTDS in response to that trauma. Journal of Affective Disorders 63(1-3): 113-121. (2001).15. Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M,Altamura C, Galecki P, Berk M. (Neuro)inflammation and neuroprogression as new pathways and drugstarget in de-pression: from antioxidants to kinase inhibitors. Prog Neuropsychopharmacol boil Psychiatry.Apr 29;35(3):659-63. (2011).

11 UK. Prof. Stuart Montgomery: St. Mary's Hospital Medical School, London and London University Schoolof Medicine Depressione ?

1 Altamura AC, De Novellis F, Guercetti G, Invernizzi G, Percudani M, Montgomery SA Fluoxetine comparedwith amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res. 1989;9(6):391-6.2 Altamura AC, Montgomery SA, Wernicke JF. Br J Psychiatry Suppl. 1988 Sep;(3):109-12. No abstractavailable. The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression.3 Altamura AC, Curry SH, Montgomery S, Wiles DH. Early unwanted effects of fluphenazine esters related toplasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology (Berl). 1985;87(1):30-3.4 Curry SH, Altamura AC, Montgomery S. Unwanted effects of fluphenazine enanthate and decanoate.Lancet. 1979 Feb 10;1(8111):331-2.]

CURRICULUM VITAE · CURRICULUM VITAE ALFREDO CARLO ALTAMURA Posizione accademica Settore...

Documents

Transcript of CURRICULUM VITAE · CURRICULUM VITAE ALFREDO CARLO ALTAMURA Posizione accademica Settore...